Survitec launches new bio skin and bio shell at DSEI - CBRNe World
Remploy’s back… - CBRNe World
Decon7 donate pallet of products to Houston PD - CBRNe World
Sanofi pulls the plug on Zika vaccine project - CBRNe World
US helps Filipino troops prepare for chemical attack - CBRNe World
Russia has destroyed all weapons containing Lewisite - CBRNe World
Equivital launching V5 of its Black Ghost system at DSEI 2017 - CBRNe World
Progeny ResQ Handheld Raman used in the battle against opioids - CBRNe World
VPI to Unveil Advanced Radiological Detection System at DSEI - CBRNe World
Harris awarded MOD contract for EOD RCV and support. - CBRNe World
FLIR Systems Receives Delivery Order Totaling $10.5 Million from the U.S. Dept. of Homeland Security - CBRNe World
CDC ‘quarantines’ its own equipment - CBRNe World
Indonesian militants planned ‘dirty-bomb’ attack - CBRNe World
Darpa awards for Mobile Force Protection (MFP) program - CBRNe World
Saab secures British Army training extension worth $26 million - CBRNe World
Singapore Government Upgrade 17 X-ray scanners to Astrophysics, Inc equipment - CBRNe World
Endeavour Robotics receives US Armed Forces order for 32 man portable SUGVs - CBRNe World
Latest Edition of Argon’s CBRNe and HazMat Training Insights newsletter available now - CBRNe World
CBRNe South America 2018 - CBRNe World
Plastic Explosives - The Barbie Bomb Plot! - CBRNe World
Air Force awards contracts for a new ICBM weapon system - CBRNe World
National Guard and DOD develop UGV for CBRN incident response - CBRNe World
Military Madness! - CBRNe World
John A. Burns School of Medicine Receives Grant to Advance Ebola Vaccine - CBRNe World
Southern Research to Target Bio-Threats under new BARDA Contract - CBRNe World
FLIR Primed - CBRNe World
FEMA awards ICF $20 million Radiological Emergency Preparedness Contract - CBRNe World
Three Injured at Borough Market after ‘Unidentified Substance’ Delivered - CBRNe World
Three New Partners Sign on for Convergence 2017 - CBRNe World
Lockheed Martin Unveil Next Generation Air and Missile Defense Radar - CBRNe World
Smiths Detection Technology Protects First Responders Against the Threat of Fentanyl Exposure - CBRNe World
First Line Technology’s Dahlgren Decon Neutralizes 100% Carfentanil in Under 5 Minutes - CBRNe World
Pittsburgh SWAT Team Exposed to Chemicals During Drug Raid - CBRNe World
Battelle Working with DHS to Strengthen U.S. Network of Explosives Detection Canine Teams - CBRNe World
A report on the analytical comparison of Raman and FT-IR is available from Rigaku Analytical Devices - CBRNe World
CBRNe South America 2018 - CBRNe World
13 Injured in Hazmat Leak at Port of Long Beach - CBRNe World
Cobalt’s RESOLVE Handheld Through-Barrier ID System to Feature at DSEI & MSPO Events - CBRNe World
Dr David Cullin of Flir Systems on radiation detection - CBRNe World
Virginia Tech develop device expected to track nuclear activity by rogue nations - CBRNe World
Bruker Aquires Field-Portable Platform for Immunoassay-Detection of Bacteria, Viruses & Toxins - CBRNe World
Integrated Biotherapeutics Inc awarded $6.6 million to develop Filovirus vaccine - CBRNe World
New research has uncovered a potential new therapy for organophosphate caused delayed neuropathy - CBRNe World
Emergent Biosolutions awarded $23 million to develop multi-drug auto injector - CBRNe World
Kuwait gets the world’s first integrated CBRN centre - CBRNe World
The Great Elector - CBRNe World
Free ENCIRCLE CBRN Workshop - CBRNe World
Research and Development Solutions to Water Emergencies Webinar - CBRNe World
MerLion and Dstl win DTRA Grant - CBRNe World
DHS Prepare Scientists to Testify in Nuclear Smuggling Cases - CBRNe World
DHS encourages research in drone forensics - CBRNe World
PyroGenesis System in Final Testing Phase - CBRNe World
Battelle Wins Contract to Help Combat Weapons of Mass Destruction - CBRNe World
Sly Fox Mission 21 Designs Rapid Prototype UAV Early Warning CBR Detection System - CBRNe World
Emergent BioSolutions to acquire anthrax treatment - CBRNe World
Argon celebrates 30 years in business and releases a new eBook - CBRNe World
Passport Systems Announces SmartShield System v2.0 - CBRNe World
Agilent purchase Cobalt Light - CBRNe World
ADS offer free workshop - CBRNe World
Khan Shaykhun and the FFM - CBRNe World
Smiths Group agrees to sell Morpho Detection’s former trace business - CBRNe World
Second Sight® MS watched the finish line at Boston Marathon 2017! - CBRNe World
PBL gains approval to advance next generation anthrax vaccine - CBRNe World
UK MOD signs into service Thales ‘game-changing’ biological surveillance solution - CBRNe World
Arktis set for exciting growth plans following $10 million investment - CBRNe World
First Line responds to fentanyl epidemic with decon solution - CBRNe World
908 Devices introduces next-generation HPMS device for first responders - CBRNe World
BBI Detection partners with OUVRY to launch the Decpol Emergency Decontamination Mitt - CBRNe World
LION gains DHS Safety Act Certification for their CBRN PPE - CBRNe World
FLIR launch portable GCMS - CBRNe World
Teamwork and experience pay off during successful destruction mission - CBRNe World
Argon deliver PlumeSim to Austrian armed forces - CBRNe World
Silent auction raises money for Metropolitan Police Federation charity at Convergence Europe - CBRNe World
CBRNe Convergence Europe great success - CBRNe World
Kappler introduces AntiFog Expanded-View Visor - CBRNe World
Bertin sell chemical stand off to Australian army - CBRNe World
Russia disposes of 97.6% of its chemical weapon stockpiles - CBRNe World
Field stripping CWA - CBRNe World
Fort Eustis joint military unit deploys to training exercises in Indiana - CBRNe World
Prime the pump - CBRNe World
Battelle and Nanotherapeutics Form Alliance to Speed Up Process of Industry - CBRNe World
Emergent BioSolutions Awarded $100 Million BARDA Contract - CBRNe World
Interested in working for CBRNe World? - CBRNe World
3M to acquire Scott Safety - CBRNe World
Battelle launches live agent test week - April 17-21 - CBRNe World
FLIR Systems Receives Delivery Order Totaling $54.2 Million from the U.S. Department of Defense for - CBRNe World
Call for Papers for Indianapolis Convergence 2017 - CBRNe World
Emergent BioSolutions Receives BARDA Task Order Valued at Up to $30.5 Million - CBRNe World
Mad fer it! - CBRNe World
Cobra helps keep Trump safe during inauguration - CBRNe World
Berkeley Nucleonics, offers new IoT Connected Nuclear Radiation Detection Area Monitoring Systems - CBRNe World
What to make of Kim Jong-Nam - CBRNe World
L3 Sonoma EO Announces Chemical Surface Detector Contract Award - CBRNe World
Saab to deliver CBRN equipment to INTERPOL - CBRNe World
Chemical, Biological, Radiological, and Nuclear (CBRN) Security - Research Report, Drivers and Restr - CBRNe World
Defense Threat Reduction Agency Awards Leidos Prime Contract - CBRNe World
Arktis set for exciting growth plans following $10 million investment - CBRNe World
Online programme for CBRNe Convergence Europe available - CBRNe World

Survitec’s new Bio Skin suit is engineered to be worn underneath any outer garment. They state it is a lightweight, discrete and breathable stretch fabric with a unique design that offers exceptional mobility, comfort and a new level of CBRN protection. Unlike traditional carbon, they claim there is no drop-off in performance due to wear or laundering and keeps its full integrity even when exposed to sea water, petroleum, oils or lubricants. It also offers full protection against toxic industrial chemicals, non-traditional agents and blood-borne pathogens such as Ebola and HIV.

The Bio Shell utilises the Gore CPCSU-2 Flex Fit technology along with the same protective properties applied to the Bio Skin and is under half the weight of traditional carbon-based suits.  It features a lightweight customisable outer layer that leverages integrated stretch fabric that delivers improved mobility, reduced heat stress, and increased system level protection. At the heart of this technology is the Gore Chempak selectively permeable membrane (SPM). Used in both the Bio Skin and Bio Shell, the SPM is engineered to offer durable and broad protection in CBRN situations combined with a reduction in thermal burden. This barrier technology allows high levels of moisture vapour (perspiration) permeability, while significantly restricting the ingress of a broad range of hazardous substances.

Also on display at the Survitec stand at DSEI is the new Sonics Milpod, a specialist man portable stretcher used for extraction and treatment of a casualty in a CBRN environment.  With more than 20 design improvements over the current legacy products on offer from other suppliers, including maritime capable flotation and significantly reduced bulk, the Milpod represents a huge step forward in CBRN mobile containment and recovery.

A long time ago, in an economy far, far away… [Really can’t do this without the scrolling… Ed.] Many British and Commonwealth (among other) soldiers and law enforcement officials grew up with the Remploy Frontline garments, the CR1, Quickdon, MarkIV or Mark IVa. Remploy was a government charity that had, originally, been designed for servicemen wounded in WW1 to get gainful employment. In time it grew to include individuals with a variety of disabilities that were given employment, and hope, by Remploy, which had a range of products in addition to the assembly of their protective suits. Remploy Frontline was one of the few profitable areas of this business, yet despite this it faced the axe in the light of new policy from the government on the employment of disabled people. To a certain amount of disappointment (and a certain amount of rejoicing from their competitors) Remploy Frontline was shut down, and their customers needed to look elsewhere for their PPE, many of whom went to Belgian company, Seyntex, for example. 

Now, however, that celebration might be short-lived as Remploy Frontline products make their way back to UK shores through the work of Haven Protective Technology Solutions and their new Australian partner OPEC CBRNe. Their new products are going to be on show next week at the UK’s DSEi show on stand S10-210.  “OPEC CBRNe is immensely proud to be able to partner with Haven to continue to provide a range of products for the next generation of military and first responders,” said OPEC CBRNe Business Development Manager, Chris Jackson. “We know there is great appreciation in the market for the return of this renowned range, and we are delighted that the good work of this social enterprise in providing meaningful employment for disabled people can continue under the OPEC CBRNe brand,” he said.
                    The ‘Kestrel’ and ‘Phoenix’ ensembles will be the new flagships of the OPEC CBRNe brand and claim to be the progeny of ‘decades of robust research and development, complemented by integration of the markets latest cutting edge technologies and an appreciation of today’s complex military environment.’ The Kestrel claims to be 30% lighter than current (unnamed) systems and as such able to deal with a high heat environment, it also claims to offer “long term comfort, breathability and ease of movement in a high threat environment.”

Kestrel was chosen by the Australian government as their preferred CBRN ensemble in December last year, and will be joined at the show by the one piece Kestrel PPE. In addition to this there is the semi permeable membrane system, the ‘Roc’ [Dwayne ‘Moana’ Johnson? Ed], which claims to be ‘high protection, quick donning CBRN uniform suitable for first responder wear, such as police, ambulance and fire services.’

OPEC Systems, has been operating in the CBRN space since 1998 as a major supplier of CBRN equipment and a respected contractor for clean-up of contaminated chemical weapons sites.

Haven states on its website ( that it provides opportunities to disabled people and we are currently awaiting further information from the press office on exactly what this means in regard to the PPE.

Equivital’s Black Ghost system provides valuable information to commanders and medics on a soldier’s temperature, heart rate, breathing rate, position and activity. The Black Ghost application also now includes a novel Heat Strain Index (HSI). HSI is the ultimate tool in estimating current heat strain and predicting an impending heat related injury. Alerts and thresholds can be tailored to each user and the data allows commanders to intervene in a timely manner when a threshold is breached.

Not only does the Equivital system provide a current estimation of heat strain, it also has the functionality to predict 15 minutes in the future the heat risk related to an individual if they were to continue in the same environment at the same activity level. This information could be vital in preventing heat stress injuries in military units worldwide. 

Anmol Sood, CEO of Equivital, comments: “Heat stress can impair a person’s cognitive function and this is dangerous for those operating in extreme and unpredictable environments. The Black Ghost system is designed to provide supporting data to a team leader or medic and reduce the burden on the individual. The Heat Strain Index empowers individuals and teams for better decision making backed up by contextualised data. Black Ghost enables commanders to provide smarter, safer training and ultimately to save lives.”

For more information about Equivital and their range of mobile human monitoring products visit their site here

A recent news piece on NBC News went inside JFK airport and filmed Rigaku’s Progeny ResQ 1064nm handheld Raman in action in the country’s war against opioids.
The video can be viewed here

This advanced RDS consists of a robust and reliable base unit with plug-in probes for detecting different types of radiation in a wide range of scenarios. The system will be manufactured in Salt Lake City by VPI Technology’s wholly owned subsidiary, D-tect Systems. The final system will be delivered in January 2018, followed by an 18-month testing period, after which it will go into full production. The DoD contract is for an indefinite delivery, indefinite quantity over the next ten years. VPI will also offer a commercial version of the RDS.

VPI’s CEO, Morgan Taylor, commented: “Winning this major contract, in a competition between several organizations, was something of a David-and-Goliath moment for VPI. We were likely the smallest
company in the bid, but also the most agile and so able to respond to exactly what the US Government wanted. Also, we were happy to let the Government have full access to all product design
documentation and data, a rare concession these days.” “The development of this project highlights VPI’s collection of outstanding skills and capabilities in world-class design, testing and qualification, and manufacturing. Also, it complements our existing radiation detection equipment line. I am especially pleased with the incredible team members we have at VPI, their hard work and dedication to the principles upon which VPI is built and their efforts on this project.”

Press briefing: VPI will be holding a press briefing on stand N4-478 (State of Utah stand) on September
13, at 1500. Photo and interview opportunities are available before and after the briefing and
throughout DSEI. Media contact: Mary Ann Griffiths, +44 (0)7887 787935,

FLIR Systems has received a delivery order for FLIR identiFINDER® R300 spectroscopic personal radiation detectors (SPRDs). The delivery order is under a five-year indefinite delivery, indefinite quantity (IDIQ) contract from the U.S. Department of Homeland Security, Domestic Nuclear Detection Office (DNDO) for the Human Portable Tripwire (HPT) program. The order is valued at $10.595 million, with deliveries extending through the third quarter of 2018.

The identiFINDER R300 (formerly called nanoRaider) is a belt-worn spectroscopic pager that virtually eliminates false alarms and false positives by providing continuous radiation detection capability and full threat identification. Under the contract, all DHS Components will be able to procure HPT systems and associated services, including warranty, extended warranty, maintenance support, training, and documentation, as needed.

We are honored to support DHS components with best-in-class technology that quickly detects illicit radiological and nuclear weapons materials. This delivery represents our commitment to provide mission-critical solutions that protect the frontline and keep our country safe. Production is being performed out of FLIR’s facility in Oak Ridge, TN.

For more information on the identiFINDER® R300, visit

In response to an inquiry from 60 Minutes, the CDC sent a statement saying, “The gowns are being quarantined within the SNS inventory and there are no current plans to use them.” The CDC’s full statement can be found here.

In April 2017 a group of hospitals sued Kimberly-Clark and Halyard Health in federal court over the alleged defects of the MICROCOOL gowns. After a nine-day trial, a jury found the companies liable for fraud and awarded $454 million in damages. Kimberly-Clark and Halyard Health are challenging the decision in court.
After the story was rebroadcast Halyard Health issued a statement to 60 Minutes saying its gowns had passed tests conducted by the CDC’s National Institute for Occupational Safety and Health,  proving that they meet the “highest standards” in the industry.  “We continue to stand behind the quality and efficacy of our MicroCool gowns,” the statement said. 
At the request of the SNS, NIOSH conducted an evaluation of the MICROCOOL gown. Specifically, the evaluation assessed whether this gown model passed the Level 4 requirements of the American Standard Institute (ANSI). A final report of findings was published on the institutes website on July 28, 2017, and shared with the manufacturer:

“The three teams we’ve assembled have innovative ideas for a versatile, layered defense system that could protect convoys on the move from multiple small unmanned aircraft systems in real time,” said Jean-Charles Ledé, a program manager in DARPA’s Tactical Technology Office (TTO). “Each team will now work to integrate novel ideas for advanced sensors and neutralization approaches into a common framework emphasizing safety for civilian bystanders, ease of operation, and low size, weight, power, and cost. Our goal is a technology demonstration system that could fit onto currently deployed tactical ground vehicles and maritime vessels—getting advanced and upgradeable capabilities quickly to the warfighters who need them.”

The MFP program is aiming for three phases punctuated by open-air demonstrations involving increasingly sophisticated threats and scenarios. The goal is for the technology demonstration system to show initial functionality at the end of Phase 1 and progressively improve, culminating in a full-capability demonstration on a moving vehicle or vessel by the end of Phase 3.

At the conclusion of each open-air demonstration, DARPA plans to offer the Services and other U.S. Government agencies the opportunity to fund extended field evaluations of the current technology demonstration system.

DARPA’s goal is to develop the interim versions and the final prototype system to meet the needs of a broad number of potential U.S. Government and commercial users.

Endeavour’s SUGV meets IP67 ratings, operates in all environmental conditions, integrates multiple sensors and hardware for increased capabilities, climbs and descends stairs, provides dexterous and robust manipulation and lift/inspection capabilities while also being capable of extending operational range through mesh networking with other deployed Endeavor systems.
The Endeavor Robotics uPoint Multi-Robot Control System consists of an Android™-based, rugged, tablet controller and Persistent Systems, LLC, MPU5 Radio network. The integration of the mesh networking with Endeavor Robotics robots is a force multiplier for our warfighters by significantly increasing the distance of unmanned ground operations and enabling operators to control or observe multiple robot assets through a common controller interface.
“All of us at Endeavor Robotics are singularly focused on the development, delivery, and sustainment of life-saving robot technology. The delivery of 32 SUGVs equipped with our uPoint Multi-Robot Control System advances the entire install base in terms of interoperability across the family of Endeavor Robotics’ systems. These systems will augment the approximately 1,000 SUGVs already in use by our Armed Forces,” said Sean Bielat, CEO. “We could not be more proud of the American warfighter and remain a dedicated partner to the United States Armed Forces.”


ADM300A V1B-SIM radiation training simulator:

Revolutionising radiation safety training for UK first responders:

What are the key outcomes of effective CBRN and HazMat training?:

“The operation was foiled because of the extra weight,” Machnouk said. “Intelligence branch followed on the case and found that Amer was involved in this act, and it appears that he was supposed to carry it out.”
Amer was detained upon arriving in Lebanon. His two brothers, Khaled and Mahmoud Khayyat, were arrested in Sydney in July and charged with “two counts of acts done in preparation for, or planning, a terrorist act.” At the time of the arrests the Deputy Commissioner for National Security, Michael Phelan, described the plan as “one of the most sophisticated plots that has ever been attempted on Australian soil.”
The plane Khayyat planned to blow up is believed to be an Etihad flight out of Sydney, with 400 people onboard, 120 of them Lebanese nationals. Machnouk went on to claim that the suspects wanted to punish the UAE and Australia for being part of an the coalition fighting Islamic State in Syria and Iraq and called on intelligence agencies to work together.

“When four Lebanese brothers in Australia decide to blow up an Emirati jet, this means that the whole world should work together to fight terrorism,” he said. “Coordination should be 24 hours a day between all security agencies to stop such attacks.”

Further to the plane plot, the brothers had also planned to carry out a second, more sophisticated plot, which involved constructing a device that would be used to stage a gas attack in a public place, using hydrogen sulphide.

The contracts were awarded to Boeing and Northrop Grumman at $349 million and $328 million respectively
Boeing’s Strategic Deterrence Systems Director, Frank McCall, hailed the contract, saying Boeing has been providing tech support for Minuteman missile since their first launch in 1961
“The Minuteman III is the enduring ground-based leg of our nuclear triad. However, it is an aging platform and requires major investments to maintain its reliability and effectiveness,” said Gen. Robin Rand, the commander of Air Force Global Strike Command. “GBSD is the most cost-effective ICBM replacement strategy, leveraging existing infrastructure while also implementing mature, modern technologies and more efficient operations, maintenance and security concepts.”
The Air Force has estimated that the project would cost US taxpayers at least $62 billion. However, the Pentagon’s office of Cost Assessment and Program Evaluation (CAPE) says the costs would surpass $85 billion.
“The new weapon system will meet the combatant commander’s current requirements, while having the adaptability to affordably address changing technology and emerging threats through 2075,” said Maj. Gen. Scott Jansson, the AFNWC commander and the Air Force program executive officer for strategic systems.

Malcolm Reese, joint program director of the Combating Weapons of Mass Destruction Division, led an effort to integrate chemical, biological, radiological and toxic industrial material sensors on re-purposed Talon IV unmanned robots, the U.S. Army said Friday.

Reese’s team also added an upgraded communication system, infrared day/night cameras and an autonomous mapping system for the CBRN robots.

Tech. Sgt. Brett Whitfill, survey team chief from the 73rd civil support team within the Kansas National Guard, said that the robots help mitigate the need for personnel to suit up for data gathering missions.

“With this [equipment] we could pull it out of our truck or trailer, set it up and send it downrange to investigate … We [can] get real-time data and real-time feedback,” added Whitfill.

ICF have supported the Radiological Emergency Preparedness Program since 2000 and since then has supported FEMA and its state, local and industry partners by providing program management, policy analysis, training and exercise evaluations designed to protect the public health and safety of citizens living near the estimated 60 commercial nuclear power plants nationwide.
“This win represents ICF’s enduring commitment to FEMA’s radiological preparedness program and to building resilient communities by preparing them for response and recovery from potential catastrophic events,” said John Paczkowski, senior vice president for ICF. “We are proud to help FEMA continue to implement this critical component of the National Preparedness System.”
FEMA established the Radiological Emergency Preparedness (REP) Program to ensure that state and local plans and preparedness can adequately protect the public health and safety of citizens living around commercial nuclear power plants.

The new array is built on a modular and scalable architecture to the Army’s requirements and, once finalized, will replace the aging Patriot MPQ-65 radar. “Incremental upgrades to the existing Patriot radar no longer address current sustainment issues, current threat performance shortcomings, or provide growth for future and evolving threats,” said Mark Mekker, director of next generation radar systems at Lockheed Martin. “Lockheed Martin is prepared to offer a next generation missile defense system that will leverage advances in radar technology to provide a modular, scalable architecture and reduce the total cost of ownership well over its 30 year lifecycle.” A video of the demonstrator can be viewed here
“Our solution for the U.S. Army’s new air and missile defense sensor is not a new-start program. It’s a combination of technology maturation over several years and includes capability leveraged from our current development programs and battlefield-proven radars. We rely heavily on our modern radar systems such as the Q-53 and the Long Range Discrimination Radar to rapidly bring low-risk, proven technology to the warfighter,” Mekker said. “We look forward to the opportunity to participate in this competition that will ultimately drive up performance and reduce costs for the U.S. Army.”

Smiths Detection Inc. (SDI) is at the forefront of arming first responders with solutions to safeguard against the presence of fentanyl. Working directly with international law enforcement and hazmat agencies, SDI has adapted a range of existing technologies to be able to quickly and accurately detect fentanyl and its analogues on scene.

Fentanyl, if inhaled, may lead to respiratory arrest, is 50 times more lethal than heroin and 100 times more lethal than morphine. It is prompting fears of a public health crisis and a threat to the safety of first responders who may not be aware of its presence during a response.

SDI has adapted three of its leading technologies to detect and identify fentanyl, including:

  •  IONSCAN 600 - used in airports, corrections facilities and security checkpoints across the world, this portable system detects invisible amounts of narcotics   like fentanyl, and explosives, in seconds.

  •  HazMatID Elite/Target ID - an infrared handheld chemical identifier performs chemical analysis on bulk amounts of solids and liquids, which may be used as   court-admissible evidence.

  •  ACE-ID - utilizes laser Raman technology which allows users to test bulk quantities of unknown substances without contact, including through plastic and   glass.

The technologies were designed to complement each other in response scenarios but can work independently. SDI also enhanced its ReachBackID 24/7 hotline to give first responders using these technologies access to Ph.D. scientists to support the field-based analysis of fentanyl and several of its analogues.

Shan Hood, Vice President of Product & Technology for Smiths Detection, said: “The new fentanyl threat to first responders is real and severe since accidental contact with- or inhalation-of very small amounts can be life threatening. The right technology can help first responders make better informed decisions about how best to protect themselves from fentanyl and its analogues during emergencies.”

First Line Technology received new lab results confirming that Dahlgren Decon neutralizes 100% of carfentanil in under five minutes.

This comes on the heels of a similar announcement from First Line Technology when they publicized last month that Dahlgren Decon neutralizes 100% of fentanyl in under two minutes. Absolute efficacy under five minutes for some of the most potent synthetic opioids known to man makes Dahlgren Decon one of the most effective decontamination solutions available.

“The data is irrefutable. It comes down to the superior chemical composition of Dahlgren Decon,” said Dr. Christina Baxter, former Program Manager for the CBRNE subgroup at the Technical Support Working Group. “Dahlgren Decon uses peracetic acid, which is double the strength of any hydrogen peroxide solution. It also comes in solid form which allows users to mix it on-site so there is no degradation of concentration. You always know what you’re getting with Dahlgren Decon.”

The data shows Dahlgren Decon yields a greater than 99.9% neutralization of carfentanil in under two minutes and 100% neutralization of carfentanil in under five minutes.

“We couldn’t be more thrilled with these results, but our work is not done.” said Amit Kapoor, President of First Line Technology. “Dahlgren Decon needs to be in the hands of every first responder, law enforcement officer and hazmat crew worldwide.”

Dahlgren Decon, manufactured by First Line Technology through an exclusive technology licensing agreement with the Naval Surface Warfare Center Dahlgren Division (NSWCDD), is a three-part decontaminant solution that immediately decontaminates chemical and biological warfare agents, and now proven to be effective against both fentanyl and carfentanil.

A complete decontamination kit including FiberTect wipes, Dahlgren Decon solution and the Victory MG200 electrostatic sprayer can be purchased through Federal Resources, a resale partner of First Line Technology. For more information on how to purchase Dahlgren Decon or the full decontamination kit, contact

For more information on Dahlgren Decon and First Line Technology, visit or contact First Line Technology at 703-955-7510 or

The team was assisting U.S. Immigration and Customers Enforcement and U.S. Homeland Security officials at the time. Acting U.S. Attorney Soo Song said that the activity was part of “an ongoing drug investigation,” and that it was conducted by Immigration and Customs Enforcement with help from city and state police and postal inspectors.
Federal officials suspect the chemical substance was fentanyl.

Called REDDI, the Regional Explosives Detection Dog Initiative, The Department of Homeland Security’s Advanced Research Project Agency dispatched its team of trainers, evaluators, and scientist early this spring, and have continued with additional sessions in Miami in June; and Long Beach, CA in July. It is all in an effort to help the canine teams realize their full potential by arming them with key information on threat materials and recent attacks, exposing them to relevant operational scenarios, and providing an opportunity for valuable odor training.
The DHS’s Explosive Detection Canine Program is working with subject matter experts from Battelle, Johns Hopkins University Applied Physics Laboratory and the Naval Surface Warfare Center Indian Head Explosive Ordnance Disposal Technology Division.

“At Battelle, we have more than 20 years of experience in canine-focused research, development, testing, and evaluation,” said Kevin Good, Senior Research Scientist. “With our teams of engineers, chemists, biologists, explosives experts and veterinarians, we are perfectly suited to provide the insight and tools necessary to understand and advance the performance of our nation’s canine teams.”

The paper “Comparison of FT-IR and Raman Spectroscopy:Identification of common chemicals in safety and security applications” produced by Dr. Suzanne Schreyer, Sr. Applications Scientist at Rigaku Analytical Devices is available to read here


To learn more about our sponsors and exhibitors click the below links.
BioFire Defense:
Federal Resources:
Meridian Medical Technologies:

The leaking chemical was identified as propyl acetate. A full response was called in comprising of a hazardous materials unit, search-and-rescue unit and paramedics as well as two Long Beach fire boats and a lifeguard rescue boat which deployed a 1,000-foot boom in the water alongside the docked ship as a precautionary measure against environmental damage. With the assistance of port staff and crane operators the leaking tank was safely removed from the ship. One worker exposed to the fumes, along with a firefighter who fell while responding to the spill, were transported to a local hospital and reported to be in a stable condition on Sunday evening. At this time the authorities do not know what cased the leak and are still investigating.

Resolve was launched in 2016 for applications in hazmat incident management, military search and EOD, first response, law enforcement, and screening at ports & borders. The system uses Cobalt’s proprietary spatially offset Raman spectroscopy (SORS) technology to detect and identify chemicals through opaque barriers such as thick coloured plastics, dark glass, paper, card, sacks and fabric. Measured spectra are accurately matched to comprehensive on-board spectral libraries and the system identifies materials including; explosives and precursors, hazardous and toxic materials, CWAs, narcotics and new psychoactive substances, plus thousands of benign chemicals.

Resolve is already deployed worldwide - in military applications as well as in hazmat response, policing and customs screening. The system was named as one of the top new products at Pittcon 2016 by Instrument Business Outlook and was a finalist in the 2016 R&D 100 Awards.

Patrick Huber, a Professor of Physics on the project explained, “Basically we’re looking at the colors of the neutrino, and in that way we can say there’s plutonium in the reactor or not”. The prototype iscurrently at Dominion Power’s North Anna Nuclear Generating Station near Richmond. But the plan would be to stretch the detection to every country in the world.
“You would put one of these next to each reactor you want to survey, and basically you have to understand that right now the International Atomic Energy Agency is inspecting about 400 reactors around the globe,” Huber said.
Johnathan Link is a Professor of Physics and Director of the Center for Neutrino Physics, he said, “We can actually replace the processes where we have to trust what people are telling us about how they’re producing and what they’re doing with the spent nuclear fuel, and instead we can track for ourselves.” Link believes rogue nations that balk at having to submit to inspections would have no reason to refuse such a small, unobtrusive device.The prototype is roughly a two-foot that weighs about 175 pounds, costing about $250,000 to make, funded by Virginia Tech and the National Science Foundation.
The actual detectors will cost about $2 million a piece. The researchers will demonstrate what they have now and hopefully get funding to build the real thing and put them around the world.
Anna Erickson is an assistant professor of  the Nuclear and Radiological  Engineering  Program  at Georgia Tech, where she researches nuclear reactor design and  nuclear detection  with a focus on the needs for proliferation-resistant nuclear power.  She is not involved with the CHANDLER project, but said the neutrino project by Virginia Tech could set a new standard for antineutrino detectors, a field stalled by tricky technology, including the sizes of previous devices too large for easy assembly, transport, and setup.  Previous detectors used liquid scintillators, rather than solid plastic as does CHANDLER.
“This could open  a  new  path for antineutrino-based reactor monitoring  technology,” she said.

The acquired assets include intellectual property, a field-portable, electrochemical chip-based detection instrument and associated consumable kits for on-site, fast identification of selected bacteria, viruses and toxins. 
Detection and identification of up to 6 bio-threats per assay chip occurs typically within 20 minutes, with excellent sensitivities and without any prior culturing steps for bacteria.  The immunoassay kits, which Bruker now can offer for bio-detection and homeland security, include:
Biothreat Test: Bacillus anthracis, Yersinia pestis, Francisella tularensis, Brucella species, Burkholderia mallei/pseudomallei, Orthopox viruses (smallpox);
Toxin Test I: Botulinum Toxins A, B, F; Staphylococcal Enterotoxin B; Ricin;
Toxin Test II: Botulinum Toxin C, D, E; Staphylococcal Enterotoxin A; Abrin;
The acquired instrument platform, the portable Bio-Detector integrated (pBDi), is ready for immediate commercial launch.  Unlike other PCR-based field methods, the unique multiplex ELISA-based (enzyme-linked immunosorbent assay) detection with a novel electrochemical chip readout, allows rapid on-site identification of various bio-threats, including toxins, with very high sensitivity.
Developed for ease of use by non-scientific personnel, the pBDi can even be operated while working in protective gear under field conditions.  Fully portable and operating from internal batteries, the pBDi can be used in ‘hot zones’.
Dr. Thomas Elssner, Bio-Detection Manager at the Bruker Detection division, commented: “We are very excited to offer the pBDi as an easy-to-use and robust detection system that was specifically designed for field applications, and which dramatically decreases the time and effort to assess the seriousness of bio-threat incidents.  Our new platform also allows the flexible development of new assays and consumables to address emerging threats.”     
Dr. Wolfgang Pusch, Executive Vice President of Microbiology & Diagnostics at Bruker Daltonics, added: “The new pBDi system leverages our recently acquired capabilities in monoclonal antibody production to enable new, fieldable immunoassay workflows for fast toxin, viral and bacterial detection, in the future also in clinical and food microbiology.  The pBDi platform is a valuable expansion of our microbiology portfolio, consisting of the MALDI Biotyper for broad and fast microbial identification, the IR Biotyper for infection control workflows, and the Fungiplex and Carbaplex real-time PCR assays for rapid molecular testing.”

“This award will enable us to address a pressing global public health need, namely a single vaccine that can protect against all ebolaviruses. To meet this challenge, we have assembled a unique team of experts in immunogen design, structural biology, vaccine development and animal models of filovirus infection,” said Dr. M. Javad Aman.

“A novel aspect of the program will be the use of state-of-the-art imaging and computational approaches. This design work will help us craft a vaccine to steer the immune response in the right directions,” added Dr. Erica Ollmann Saphire.

“We are excited to participate in this collaboration and to test novel immunogen design strategies for their ability to focus antibody responses to conserved epitopes on ebolaviruses. This will be a fantastic test for structure-based vaccine design, and it may give us insights on how to make vaccines for other more variable viruses,” added Dr. William Schief.

Dr Zhaobing Gao, lead author from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, said: “In our study we have begun to unravel the biological mechanism which causes organophosphate-induced delayed neuropathy. Using our expertise in drug discovery we were also able to screen a Federal Drugs Administration approved drug library of around 2,000 drugs and identify two potent drugs, duloxetine and ketotifen, which alleviated the signs of neuropathy in an animal model.”

Dr Gao added: “Our study provides compelling evidence that TRPA1 mediates OP-induced neuropathy and that TRPA1 can be targeted effectively with existing drugs that are approved by the Federal Drugs Administration. Further research will need to be conducted to assess the applicability of our findings to humans.

Under the terms of the five year contract Emergent must develop the device as well as demonstrate consistency in manufacturing, functionality and usability of the final device and undertake regulatory activities required to obtain FDA approval for use of the auto-injector in a bioterrorism incident.
“Ease of use and rapid delivery of antidotes are critical features of auto-injectors that are intended to mitigate the health effects of nerve agent exposure,” Adam Havey, executive vice president of Business Operations at Emergent, said. “Emergent’s device seeks to satisfy the requirements of the Department of Defense (DOD) for a novel auto-injector platform technology, and we look forward to collaborating with our development partners to meet the DOD’s needs.”

This is the first centre in the world to cover a whole country with both fixed and mobile CBRN sensors and units. The centre also provides a unique capability for simulated training.
“This CBRN centre in Kuwait strengthens our position as a supplier of advanced CBRN solutions. Our ability to take the prime contractor role for this ground-breaking CBRN solution is built on deep expertise and innovations in CBRN technology. It also derives from our detailed knowledge of C4I – Command, Control, Communications, Computers, and Intelligence systems – as well as systems and platform integration”, says Torsten Öhman, acting Head of Business area Support and Services within Saab.

On 26 July the Organisation for the Prohibition of Chemical Weapons (OPCW) circulated a note to the Executive Council (EC) members outlining the procedures for electing its fourth Director-General (DG) (Ambassador Ahmet Üzümcü’s second, and final, term ends next year). On 13 September EC members will conduct their first informal straw poll for seven shortlisted candidates. All made presentations at the EC earlier this month.

The candidates are: Fernando Arias (Spain), Abdouraman Bary (Burkina Faso), Saywan Sabir Barzani (Iraq), Won-soo Kim (South Korea), Tibor Tóth (Hungary), Jesper Vahr (Denmark) and Vaidotas Verba (Lithuania). Ambassador Arias is Spain’s Permanent Representative to OPCW. Bary is currently Africa’s Regional Coordinator for chemicals and waste at the United Nations Environment Programme. He previously headed Burkina Faso’s National Authority to the OPCW. Ambassador Barzani is Iraq’s Ambassador to the Netherlands. Won-soo was Under Secretary-General and High Representative for Disarmament Affairs under former UN Secretary-General Ban Ki-moon. Tóth was formerly the Executive Secretary of the Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization (CTBTO). From 1995-2001, he chaired an ad hoc group that negotiated a protocol (which was not adopted) to strengthen compliance with the 1972 Biological and Toxin Weapons Convention. Ambassador Vahr was previously Director of the Private Office of the NATO Secretary General. Starting in September 2014 Ambassador Verba ‘assumed the responsibilities’ of Project Co-ordinator in Ukraine for the Organization for Security and Co-operation in Europe’s (OSCE). He was previously Lithuania’s Permanent Representative to the OPCW where he took an interest in dumped chemical weapons issues.

In September the EC members will complete their initial ballots. The first preference will receive 7 points, the second preference will receive 6 points and so forth. As those who receive the fewest votes drop out, the support of the EC should coalesce around a single candidate. Only EC members in good standing will be permitted to participate. In principle, members lose their vote if they are in arrears in payments for an amount that equals or exceeds the amount of contributions due from them for the preceding two full years. In 2009 the EC took 5 straw polls to achieve consensus on Ambassador Üzümcü’s candidacy.

The states parties wish to have confidence that their views will be heard and that the organization will be in a ‘safe pair of hands’. EC members are evaluating the candidates partly in terms perceived personal or prior institutional partiality they may have vis-à-vis the Syria chemical weapons file. Some EC members may consider NATO affiliation (the current DG has such an affiliation) or OSCE monitoring of the Ukraine armed conflict as problematic. Candidates who have refrained from expressing substantive views publicly could be favoured.

Some observers have noted that all the shortlisted candidates are men and that the percentage of women in the top leadership of OPCW should be increased. While civil society and others may support changing the selection process for UN-type organizations (e.g., by increased transparency and non-government inputs), the selection process for multilateral disarmament and arms control regimes remains the prerogative of governments and will continue to reflect broader geopolitical realities within the international system. As such, governments will continue to reach common understandings on the ‘political acceptability’ of individuals and to link such appointments with achieving understandings regarding other geopolitical processes and decisions outside the Chemical Weapons Convention (CWC) context.

In addition, all top Technical Secretariat positions will be subject to change so as to reflect the principle of ‘equitable geographic distribution’. The CWC groupings are: Africa; Asia; Eastern Europe; Latin America and the Caribbean (GRULAC); and Western European and Other States (WEOG). New heads of organizations also typically bring some of their own people with them.

The new DG will also oversee the definitive transition of the treaty regime towards a post-chemical weapons destruction phase. At least two visions may be realised: one of an OPCW focused on chemical weapon threats with most resources allocated accordingly, the other for the OPCW to serve as a model of international outreach and capacity-building for the peaceful uses of chemistry. Notwithstanding the experience gained in Syria, Iraq and Libya, as well as the OPCW knowledge management system, the institutional capacity of the Technical Secretariat will remain under some stress in the coming years.

Decon7 Systems, a veteran-owned chemical defense company that develops and manufactures tactical decontamination solutions for military, public safety, and security professionals worldwide, announced that their patented D7-DF200 formula can effectively neutralize one of the country’s most aggressive modern menaces: fentanyl.

With a mission to prove the efficacy of D7-DF200, the Decon7 team assembled a Fentanyl Working Group which included their staff chemist, chemists from both third party and government labs, and numerous decon experts from local, state, and national agencies across the US. This collaborative effort resulted in the establishment of test standard protocols for the efficacy of decontamination agents against the fentanyl family of synthetic opioids for application in tactical environments.

After several months of working diligently to create procedures based on the Oxidative Degradation of Fentanyl in Aqueous Solutions of Peroxides and Hypochlorite, Defence Science Journal, Vol. 61, No. 1, January 2011, pp. 30-35, (Lihong Qi, Zhenxing Cheng, Guomin Zuo, Shanmao Li and Qiping Fan) and recent Edgewood Chemical and Biological Center (ECBC) testing, protocols were finally validated last week. As a result, test protocol included a minimum fentanyl concentration of 10,000 nanograms so that both GC/MS and LC/MS can accurately identify neutralization and by-products when in contact with the decontamination agent being tested. It was found that testing at lower concentrations could interfere with acquiring accurate quantitative results.

During the initial run of tests with these high standards, D7-DF200 was able to eliminate over 97% of certified fentanyl in 5 minutes. These new test results add to the already broad-spectrum efficacy of D7-DF200 against blood-borne bacteria and viruses (HIV/AIDS, MRSA, Tuberculosis, Ebola, Avian Influenza), chemical and biological warfare agents (CBWs), toxic industrial chemicals (TICs), and volatile organic compounds (VOCs).

As a result of the urgent need from our first and military responders, Decon7 Systems and their Fentanyl Working Group are diligently working to progress an “Opioid Response Kit” into full scale production. In order to do so responsibly, they are awaiting a thorough final review of data by an additional independent laboratory and operational validation from the field. In addition to D7-DF200, they are exploring dry decon, wet wipe, and “super soap” options to include in the Opioid Response Kit.

Currently, Decon7’s BDAS+ units alone offer law enforcement personnel and first responders a safe, portable, disposable, ready-to-use solution for decontamination of fentanyl and fentanyl-related substances from equipment, PPE, vehicles, building materials, uniforms, and more.

This workshop is your chance to provide insights on the missing capabilities and what ENCIRCLE can do to fill them. With practitioner support the consortium will also conduct a new threat assessment in order to take into account new needs (new threats) and technologies. The final session of the workshop will be dedicated to CBRNe Procurement and Policy.
To book your free place visit

The webinnar will provide an overview of the following tools and methods:
• EPANET-RTX (Real–time eXtension) which are software libraries to support real-time modeling and real-time analytics of water distribution systems.
• Water Network Tool for Resilience (WNTR) which can be utilized to model and evaluate the resilience of specific water distribution systems.
• Riverine Spill Modeling System (RSMS) that supports emergency response decisions regarding drinking water plants intakes on the Ohio River.  There are plans to expand this tool to other river systems.
• Decontamination methods for oil spills that impact water distribution systems, and treatment of contaminated water. 
Resources supporting risk assessment activities that state laboratories and public health and environmental agencies undertake will also be presented.  A key resource, the Selected Analytical Methods for Environmental Remediation and Recovery that assists sampling and analytical method selection, will be featured.  Current research on potential exposure pathways related to high consequence pathogens (e.g., Ebola virus, Bacillus anthracis spores) in wastewater will also be summarized.

The multiyear project will investigate finafloxacin as a potential treatment for Burkholderia pseudomallei, other biothreat agents including Francisella tularensis and Yersinia pestis, and additional multidrug-resistant (MDR) pathogens. MerLion and Dstl will initially aim to win FDA agreement on the next steps for developing the antibiotic candidate.
“We already have compelling preclinical results generated in the collaboration with our partners from Dstl for finafloxacin’s activity against various biothreat pathogens, as well as data from our positive clinical studies treating patients with cUTI infections,” said David Dally, CEO of MerLion. “The new project will enable us to investigate the activity of finafloxacin against a variety of very difficult-to-treat pathogens in more detail and will help to position finafloxacin as an effective therapy against multiple bioterrorism threats, as well as a treatment for other life-threatening infections.”

The DHS delivered a presentation about planning for a national educational program to prepare scientists to serve as effective expert witnesses in cases of nuclear smuggling.
DHS’s nuclear forensic educational awareness program enables scientist participants will have the opportunity to practice their skills using a fictional set of nuclear forensic case materials. The program covers every step a scientist would take in preparation for an actual court appearance and will conclude in a mock trial. Expert feedback and lessons learned provide participants with a set of technical and communication skills that will be invaluable should they serve as nuclear forensic witnesses in a real court setting.

The drone forensics work will focus on conducting cutting-edge research that will address key aspects of collecting digital forensics data from drone systems. During the research, VTO will target the identification and definition of the various data types residing on drones and their connected systems, including drone board systems, flight controllers, connected mobile devices and computers, onboard cameras, and network communications between a drone and its controller. The company also will seek to identify each drone’s data-acquisition method, including logical and physical acquisition opportunities such as circuit board-level interface (JTAG) and flash-memory removal (chip-off) to identify data artifacts on drones.

The project’s final deliverable will be a website that will support law enforcement officers, forensic services specialists and researchers. This website will be populated with instruction information obtained from the complete physical teardown and analysis of sample consumer- and professional-level drones as well as their connected controllers and peripheral devices.

“This drone forensics project will provide law enforcement the ability to extract and analyze evidentiary data from expensive and sophisticated professional drones to relatively simple store-bought drones,” said Megan Mahle, Program Manager in S&T’s Homeland Security Advanced Research Projects Agency (HSARPA). “This is a capability the law enforcement community needs, especially as the popularity of drones and their use in criminal activity continues to grow.”

The award is part of the S&T Cyber Security Division’s (CSD) Cyber Forensics project, which develops cost-effective and novel cyber forensics solutions that help law enforcement keep pace with advances in technology. The project focuses on development of new capabilities to help law enforcement with the forensic investigations of digital evidence from various devices such as mobile phones and automobile infotainment systems.

CSD’s mission is to enhance the security and resilience of the nation’s critical information infrastructure and the Internet by developing and delivering new technologies, tools and techniques to defend against cyberattacks. The division, which is part of S&T’s HSARPA, conducts and supports technology transitions and leads and coordinates research and development among DHS components, government agencies, the private sector and international partners. More information on CSD

The final phase of testing, expected to take around six months, will be conducted using live chemical agents and it is expected to confirm the results produced at PyroGenesis’ facilities when using surrogate chemical agents.
“We are highly confident that our System will pass the Final Testing Phase particularly given the fact that we significantly exceeded the minimum requirements of 99.99% destruction efficiency using surrogates,” said Pierre Carabin, Chief Technology Officer of PyroGenesis. “As previously announced, our System demonstrated more than 99.9999% efficiency using surrogates which emulated destruction of such chemical warfare agents such as sarin (GB), soman (GD), and mustard (HD). This additional contract will allow PyroGenesis to support testing using real chemical warfare agents at a secure site.”
The PACWADS has been shipped to a secure site and the final phse of testing has started.

Under the terms of the award, Battelle will provide technical subject matter expertise to study, analyze, advise, research, and develop deliverables to advance the NGB’s homeland defense and security mission requirements in combatting weapons of mass destruction.
The NGB and Department of Defense have established multiple Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE) teams to respond to any natural or man-made disaster. These teams are usually the first DoD responders to support civil authorities at any domestic CBRNE incident that may result in catastrophic loss of life or property. Their function includes planning and conducting casualty search and extraction; emergency medical triage, treatment, and patient stabilization; and mass casualty decontamination. They also provide security in support of law enforcement in such situations.
These teams require equipping, training, and evaluation of all personnel to enable mission success—areas that have all grown substantially over the past decade.
Specifically, Battelle will develop CBRNE and WMD elimination exercises and after-action reports; develop and conduct training courses and assess training effectiveness; and provide technical and analytical assessments to enhance survivability, safety, and sustainment operations during an intentional and unintentional release of CBRNE materials during natural or man-made disasters within the United States and US territories.
“This important contract award again demonstrates that Battelle wins competitively bid contracts in our area of expertise—CBRNE defense and R&D operations,” said Matthew J. Shaw, Vice President and General Manager for Battelle’s CBRNE Defense business unit. “We look forward to continuing to support our government clients as they tackle these strategically important tasks to protect the homeland while keeping our warfighters and first responders safe.”

The modular CBR detection system accommodates multiple sensor modules across multiple UAV platforms, enabling Sailors to better protect themselves from the increasing frequency of CBR attacks by relaying threat data to command and control assets. Hundreds of Navy civilian and military personnel witnessed this reality as the mission culminated with a technological capability demonstration on the Potomac River Test Range, June 15.
Early in the design phase, the team decided to integrate existing CBR detection technology into SCAPEGOAT, avoiding major modifications of CBR sensors and UAS platforms that involve strict payload weight limitations. Their decision led to a system design with three interchangeable mission modules – one each for the chemical detection, biological, and radiological detection capabilities.
Moreover, the chemical and radiological detection modules are compatible with currently fielded military sensors. The biological collection unit is a custom NSWCDD-designed module compatible with currently fielded filter media that uses a 12-volt fan to pull air through the system.
In addition to CBR detection systems, SCAPEGOAT features modules for communications, a global positioning system, camera, and power.

Under the deal announced Wednesday, Emergent will pay $76 million cash upfront and up to $20 million in product sales and milestone payments to acquire Raxibacumab, a drug used to treat inhaled anthrax.
The deal will add to Emergent’s portfolio of countermeasures for infectious diseases and advance the company’s goal of growing business at its recently expanded Baltimore manufacturing facility. The drug comes with a $130 million federal contract. In partnership with the federal government, Emergent spent $80 million to double the size of its manufacturing plant near Johns Hopkins Bayview Medical Center.
As one of three Centers for Innovation in Advanced Development and Manufacturing, the facility can be called on by the federal government to mass-produce flu vaccines and has received contracts to manufacture drugs for other public health threats, such as Ebola and Zika.
Emergent already produces a vaccine for adsorbed anthrax known as BioThrax at its facility in Lansing, Mich., for the U.S. Centers for Disease Control and Prevention and the federal Biomedical Advanced Research and Development Authority. The company also is developing NuThrax, a next-generation vaccine for adsorbed anthrax, which is currently in trials.
The Raxibacumab deal comes on the heels of Emergent’s announcement last week that it plans to acquire a smallpox vaccine from Sanofi for up to $125 million, including $97.5 million in cash upfront.

Argon Electronics, the global leader in Chemical, Biological, Radiological, Nuclear (CBRN) and HazMat training systems, celebrates 30 years in business this month and, in commemoration, has released an eBook that explores the three key types of Chemical Warfare Agent (CWA) training: Live Agent Training, Simulant Agent Training and Simulation Training.

“It seems only a relatively short time ago that discussions with Essex County Fire and Rescue Service relating to their desire to enhance radiological hazard training after the Chernobyl reactor accident resulted in Argon entering the field of CBRN simulation” reflected Steven Pike, Managing Director and Founder of Argon. “Fast forward some 28 years, and our training systems, underpinned by numerous patents and commercial relationships with many of the world’s leading detector manufacturers, are in use throughout the world to enhance CBRN training.”

To celebrate this achievement, Argon has launched a new website and has also released an eBook, which will help those organisations reviewing their CBRN and HazMat training consider some of the options available. “This is our first eBook, and the contribution from David Butler BEM, a former military officer at the UK Defence CBRN Centre Winterbourne Gunner has ensured interesting reading. At a time when hardly a month passes without mention of a CBRN-related incident in the news, the need for organisations to ensure they are well prepared has never been greater.” affirmed Pike.

The eBook considers a number of factors relating to effective Chemical Warfare Agent training - including health and safety, regulatory burdens, the environment and costs.

The new eBook is available to download, free of charge, from the Argon website.

Passport Systems, Inc. announced the release of version 2.0 of its SmartShield™ Networked Radiation Detection System software. In addition to its groundbreaking Analysis function, the SmartShield system now includes the SmartShield Source Simulation application that allows users to electronically inject a simulated radioactive source to provide a full fidelity simulation of an actual event.  For the first time, customers can train to find either a stationary or a moving source without deploying a physical source.

“This could change the game for how we train ConOps,” said Tom Hughes, Director of Product Management for SmartShield Technology. “The SmartShield Source Simulation application enables hazmat units to train without the logistics of radiation sources, in public areas should they choose, using the equipment that they would use in day-to-day operations.  This type of training allows agencies to reevaluate and modify ConOps to meet the growing radiological threat.”

The SmartShield system is comprised of small gamma-radiation detectors that collect radiation data and transmit the information wirelessly through smartphones, forming a network that allows security forces to simultaneously respond to any threats. While on patrol, security and law enforcement officers collect background radiation data. When gamma radiation is detected, an alert and GPS coordinates are sent throughout the network, to a central command station, and to responding law enforcement personnel.

The capabilities of the revolutionary SmartShield system have been expanded:

• SmartShield Source Simulation, our all-new simulation tool.
• Extended battery life.
• Includes Analysis Mode, to compare previous radiation maps, and highlight changes in detected isotopes across the survey area.
• Includes Replay Mode, to playback a previous survey, allowing for closer review of previous events.
• Compatible with Samsung Galaxy S4, S6, and S7 phones.

These new capabilities are part of the continuing evolution of the SmartShield System, demonstrating that radiation detection technology does not have to be static and stagnant.  Making the software application stronger, less dependent on particular smartphone models is a move that will enable SmartShield technology to be platform independent in the future.

“The SmartShield system and source simulation application will continue to set the standard for the radiation detection industry,” said Dr. Robert Ledoux, President, CEO, and Director of Passport Systems, Inc. “Together with our recent NCS4 lab evaluation, these expanded capabilities represent a dramatic growth in our ability to protect people and events.”

In the United States, the SmartShield technology has been used to beef up security at the NCAA Final Four Basketball Tournament in Houston, at the Boston Marathon, and other crowd gathering events, such as NASCAR races in New Hampshire.  Internationally, it is being marketed for use at celebrations, soccer matches, concerts, as well as airports, and ports.

Agilent Technologies Inc. announced it has acquired Cobalt Light Systems, a provider of highly differentiated Raman spectroscopic instruments.

Cobalt’s innovative suite of benchtop and handheld/portable Raman spectroscopic instruments are based on proprietary technologies that enable through-barrier identification of chemicals and materials. Cobalt’s solutions can analyze whole tablets or inside sealed containers reducing the need for quarantines and time-consuming sample processing and testing in pharmaceutical QC, hazardous chemical ID, and security. The result is significant time, cost, and resource savings for customers as well as increased safety for certain market segments such as first responders or air passengers.

Cobalt’s customers include more than 20 of the largest 25 global pharmaceutical companies, and more than 75 airports across Europe and Asia-Pacific, including eight of the 10 largest European airports, with over 500 devices deployed at airport checkpoints. Recently, Cobalt has entered the hazardous substances market with its handheld platform.

“This is exactly the type of acquisition that Agilent’s strategy calls for – one that expands our market share and provides immediate benefits to our customers,” said Patrick Kaltenbach, president of Agilent’s Life Sciences and Applied Markets Group. “We’re focused on delivering best-in-class solutions to our customers, and Cobalt’s Raman spectroscopy product and team meet and exceed that criterion.”

“Cobalt and Agilent have similar cultures focused on customer-centric innovation,” Cobalt CEO Paul Loeffen said. “The combination of Cobalt’s patented technologies with Agilent’s product-development expertise, manufacturing capabilities, channels and customer base will allow us to scale our operations to take advantage of this rapidly growing market.”

Agilent is acquiring Cobalt for £40 million in cash. Cobalt is privately held with 52 employees, most of whom are expected to join Agilent. Cobalt’s CEO will remain with Agilent as the Director of Raman Spectroscopy. Oxford will become Agilent’s global center for Raman spectroscopy. Cobalt has received numerous prestigious awards since the company was founded in 2008 including The Queen’s Award for Enterprise in 2015 and the 2014 Royal Academy of Engineering MacRobert Award. It was also ranked as one of the U.K.’s fastest-growing technology companies in 2014

ADS would like to invite you to their annual Warrior Expo East event, held July 13 - 14, 2017 at the Virginia Beach Convention Center, Virginia Beach, Va. Warrior Expo has grown in attendance each year and now has an estimated 3,000 federal and military personnel over the two day period. The reason for the incredible turnout is due to educational breakout sessions discussing current and relevant topics, over 300 exhibitors displaying their latest products and technology, and interactive display areas. The event is free to attend and they hope you can make it.

CBRNE, Robotics, and FES Exhibitor Listing

Kappler ADS CBRNe FIRE Rigaku
AVON Draeger SPO, Inc
RINI Technologies
NucSafe Basic Concepts Lion Group
Bauer Compressors
Cobalt Scott Safety Fireblast
Power Hawk
Endeavor Robotics
Med-Eng Mistral
United Tactical Supply
IED Detection
Inert Products QinetiQ

On 29 June the OPCW’s Fact-Finding Mission (FFM) in Syria issued its report concluding that sarin (or a sarin-like chemical) had been used at Khan Shaykhun (Idlib Governate) on 4 April 2017 (unrestricted report no. S/1510/2017). The attack prompted the United States to launch 59 Tomahawk cruise missiles against the Syrian government’s Shayrat Air Base three days later. Syria, with active support from Iran and Russia, denied engaging in chemical warfare. The FFM’s report has now been transferred to the OPCW-UN Joint Investigative Mechanism (JIM) in Syria in New York in order for it to establish and attribute responsibility for the attack. The FFM report, which was more broadly distributed Friday, is part of the ever growing mass of information and analyses concerning the continued use of such weapons in the Syrian civil war which began in 2012. The United Nations Security Council and OPCW Member States remain unable to agree Syrian Government responsibility for any of the continued instances of chemical warfare.

While the FFM did not visit the site and could not determine the nature of the dispersal device, it did conclude that the deaths and casualties were caused by sarin (or a sarin-like chemical) emanating from a single crater. This crater has been the topic of intense discussion and debate as to what munition created it and whether the chemical warfare agent originated from this crater. The FFM established the soil in the crater carried sarin, isopropylmethylphosphonic acid (IMPA), diisopropyl methylphosphonate (DIMP) and hexamine. Syria declared hexamine to the OPCW in its prior chemical weapons declarations. Sarin-like may refer to the detection of the methylphosphonate functional group in the biomedical samples which, in turn, could theoretically derive from a sarin analogue based on a different alcohol.

Overall the FFM based its conclusions on biomedical specimens, interviews and official and non-official reporting and analyses. FFM members were present at autopsies (probably carried out in Turkey). The information baseline included open sources. The selected open sources cited are mainly twitter and youtube videos (this is not reporting by think tanks or universities, or CBRNe World).

The political splits within the OPCW Executive Council and UN Security Council show no signs of easing. The G20 Summit will be held in Hamburg on 7-8 July. Russian President Vladimir Putin and US President Donald Trump have confirmed attendance. Will the FFM’s findings be placed on the G20 meeting agenda or might they be discussed at the margins? The smooth and effective functioning of the CWC treaty regime remain at heightened risk irrespective of the eventual outcome of the Syrian civil war and associated geopolitical arrangements.

John Hart
Senior Researcher
Stockholm International Peace Research Institute (SIPRI)

1 Jun 2017
Smiths Group plc (“Smiths Group”) today announces that it has entered into a binding agreement with OSI Systems Inc to sell the explosive trace detection business formerly owned by Morpho Detection (the “Trace Business”) for an enterprise value of $75.5 million.
In connection with its acquisition of Morpho Detection from Safran, Smiths Group had made commitments to the European Commission (“EC”) and the Department of Justice (“DOJ”) to sell the Trace Business. The sale is conditional upon regulatory approval in Portugal and the approval by the EC and DOJ of OSI Systems Inc as a suitable purchaser. Completion is expected in mid-2017.

In April 2017, Bertin Instruments went to Boston to present its device, Second Sight MS standoff gas cloud detector, and help for the surveillance of Boston marathon. For this event, two Second Sight MS were deployed to monitor the arrival of the marathon on Boylston Street.

The Second Sight MS were placed face to face with a direct view on the finishing line: one on a rooftop and the other on a bucket on the street, with a distance of 1 km in between. Thanks to a wireless solution, the supervision and monitoring was done from the control room in the hazmat firetruck. In that configuration, the Second Sight MS were able to detect any gas attack that could happen.

PBL’s $5.6m contract from NIAID supports the advanced development of candidate vaccine components and technologies that accelerate the immune responses for use in post-event settings following the intentional release of the Category A priority pathogen Bacillus anthracis, the bacterium that causes the disease anthrax, or in response to naturally occurring outbreaks of the disease. PBL is working with Public Health England and US Company NanoBio Corporation’s novel adjuvant technology to produce a more effective product than current licensed vaccines by enabling immunity to be achieved in fewer doses and via intra-nasal delivery, instead of injection. 

PBL and its partners will now progress to manufacturing the vaccine for evaluation in a pre-clinical study, followed by a Phase 1 clinical trial. The total value of the contract (number HHSN272201600045C) could be worth up to US $24million over its 8 year term, if all options are exercised.

Commenting on the award, Dr Roger Hinton Managing Director of PBL said “NIAID’s approval to progress funding of the contract is testament to the tremendous amount of hard work and dedication that has gone into the development of this novel product to date by PBL and its partners in collaboration with NIAID’s technical team.  It both recognises the knowledge and expertise of our staff and demonstrates the ability of PBL as a young and growing company to deliver.  This programme is a continuation of our track record of developing and manufacturing life-saving and protecting products many of which are sold in worldwide markets which includes the UK anthrax vaccine.

In procuring the BSCS system, the MOD has recognised the evolving challenge of protecting against biological attacks and their asymmetric nature. The BSCS system can be used in both military and civil situations, and, in military applications, is designed to protect UK’s deployed forces overseas from biological attack. BSCS is the latest biological protection capability to be developed for UK military forces. Developed by Thales in partnership with Dstl and DE&S, BSCS builds upon lessons learnt from previous systems, deployed operations and prototypes. BSCS’s export variant called ‘Spinnaker’ can be used to protect civil areas such as sporting stadia, and large public spaces therefore it can be used to protect major national sporting events, critical national infrastructure, large scale public gatherings etc.

Thales has built and led a partnership of 26 organisations to develop the BSCS system, 18 of which have been UK SMEs. Technical partners, including Williams Advanced Engineering, have been selected from all over the UK to build this leading edge technical solution.

Air Commodore David Lee who was responsible for the delivery of this capability into service said “BSCS is a critical capability for our deployed forces in an uncertain world. Asymmetric Warfare has presented CBRN challenges, the most recent of which being the chemical attacks in Syria - the biological threat to our forces is no less critical. The integrated project team of DE&S, Thales, Dstl and the RAF Regiment have worked extremely hard over the last two years to develop this world-leading and unique system which has now reached its Initial Operating Capability (IOC).

Wing Commander Chez Davies, officer commanding 20 Wing RAF Regiment, the unit that will operate BSCS, said “The capability is designed to maximise the probability of detection at locations with a high concentration of UK Defence personnel. The superb degree of confidence provided by BSCS is game changing and will allow commanders to take action in a timely manner to maximise the protection of our people.”

Gareth Williams, VP Secure Communications and Information Systems of Thales UK Ltd said “We are delighted to be delivering this first of 6 systems to the UK MOD. It has been a challenging and interesting programme to deliver. Our team has developed a leading edge biological surveillance capability through excellent cooperation with the experts at Dstl and DE&S. This system has been developed with over 30 UK supply chain organisations, 17 of which have been SMEs. We look forward to delivering the remaining 5 systems and building our positive working relationship with Dstl and DE&S.

[There will be more information on BSCS in the June issue of the magazine. Ed.]

Venture Capital firms b-to-v Partners AG and AM-Tec Kredit AG, managed by aventic partners AG, have joined existing investors in committing $10 million in new funding. Arktis’ mission is to provide smart tools to avoid trafficking of illicit radiological and nuclear materials around the globe. The new investment will enable the company to step up production of its next generation radiation detection systems, which feature proprietary technology developed by the scientists and engineers at its headquarters in Zurich. Their products leverage the use of natural helium as opposed to the scarce and expensive He-3 isotope or other, sometimes even toxic materials used in many legacy systems.
Demand for its systems is growing rapidly and the company has recently secured contracts with the Defense Advanced Research Projects Agency (DARPA) in the US, supporting its revolutionary SIGMA program, as well as with the UK-based Atomic Weapons Establishment (AWE). In addition, it has won a contract at the port of Antwerp for seven radiation portal monitors fully integrated into the port’s infrastructure and with the Swiss authorities for radiation detection.
Arktis works with governments and agencies across the globe, supplying systems that improve security at ports, airports and border crossings. Its products are also well received in the nuclear safeguards community, which includes working with the University of Florida, the Korean Institute for Nuclear Nonproliferation and Control (KINAC) and Korean universities to improve the safe storage of spent nuclear fuel.

Rico Chandra, Chief Executive Officer of Arktis Radiation Detectors, said the new funding will accelerate the company’s continued growth and enable it to exploit the opportunities that are now emerging for its technology, particularly in the US and Europe. It will also allow the company to explore new market opportunities, expand its sales force and ramp up production for volume manufacturing.  He commented: “This new investment comes at a very exciting time for our company and will provide a massive boost to our expansion plans. Our systems are already making a major contribution to security across the globe and we continue to see a growth in demand. We will now be able to focus on bringing our portfolio of products to a whole new range of customers.”

Dr. Peter Balsiger, prospective board member for Arktis Radiation Detectors representing shareholder AM-Tec Kredit AG, said: “AM-Tec Kredit AG supports the most promising high-tech companies in Switzerland with expertise, entrepreneurial support, equity, networking and strategic know-how. We identified Arktis as one of the most promising technology companies and were particularly impressed by its market segment, trend, vision, product maturity, founders and team, as well as the sales ramp-up. We are happy to support its fast growth plan and to be part of what we believe will be a great success story.”

The data from an undisclosed agency shows Dahlgren Decon yields a greater than 99% neutralization of fentanyl in less than five minutes. This comes at a crucial time when there is no sign of the opioid addiction and overdose crisis slowing down. In fact, earlier this month, the U.S. Drug Enforcement Administration issued a warning to the public and law enforcement nationwide about the health and safety risks of fentanyl. Dahlgren Decon, manufactured by First Line Technology through an exclusive technology licensing agreement with the Naval Surface Warfare Center Dahlgren Division (NSWCDD), is a three-part decontaminant solution that immediately decontaminates chemical and biological warfare agents, and now proven to be effective against fentanyl.

“The combination of reactivity, compatibility and stability makes Dahlgren Decon a true triple threat,” said Amit Kapoor, President of First Line Technology. “It is the only general purpose decontaminant that neutralizes a broad range of hazardous agents with a neutral ph and off-the-chart material compatibility.” First Line Technology agrees that Narcan is an effective antidote for counteracting opiate overdose internally, but stresses that copious amounts of soap and water needed for external decontamination of skin and personal protective equipment (PPE) is not always readily available in situations when first responders have encountered these drugs. “This new data proves that Dahlgren Decon is a game changer for first responder and law enforcement communities,” said Gary Sharp, Director of Training at Federal Resources. “No other solution on the market neutralizes fentanyl in such a short amount of time.”

First Line Technology sees Dahlgren Decon becoming a go-to product for all first responders and law enforcement officers who find themselves handling lethal evidence or helping overdose victims. “Time is of the essence for these brave men and women,” said Kapoor. “Storing Dahlgren Decon in the trunk or passenger side of all responder vehicles would significantly reduce the risk of danger for those answering the call to help. Having an effective and proven decontamination tools is critical to our First Responders and receivers.”

Designed for true trace-level detection and identification across a variety of CBRNE and Hazmat response missions, MX908 complements the success of 908 Devices’ first-generation device M908TM. This device is deployed globally and protects communities across the United States with at least one device fielded in every state. The enhanced power of HPMS enables MX908 to provide civilian, federal and military responders with new and improved target detection and identification capabilities. This includes increased sensitivity that is up to 1,000 times greater than previous generation devices, and a new simultaneous dual-mode ionization for even broader threat category coverage.
“M908 continues to bring unprecedented and sorely-needed capabilities to the first responder toolkit, but we didn’t want to stop there,” said Dr. Kevin J. Knopp, President and CEO, 908 Devices. “It is critical that first responders keep pace with growing threats, which is only possible through continuous innovation. This belief has guided our tireless R&D efforts to strengthen and expand the applications of our HPMS technology by way of MX908.”

With MX908, elite responders will benefit from unmatched versatility and detection power. The device features an upgraded all hazards target list, which includes a broader spectrum of chemical warfare agents (CWA) as well as explosives and high-priority toxic industrial chemicals (TIC). From military grade, commercial and improvised explosives to novel threat materials, MX908 empowers responders to solve the challenges associated with today’s threat landscape. The MX908 target list will continue to evolve to include new threat categories that will address the chemical dangers currently fueling community epidemics, public safety concerns, and military response.

“This landscape is extremely diverse, with responders constantly managing the disparity between fighting the familiar while also facing countless unknowns,” said John Kenneweg, Vice President, 908 Devices. “With the launch of MX908, we are delivering a next-gen device designed to address a wider range of applications, equipping responders with the detection and identification capabilities they need to combat today’s modern threats.” 
MX908 weighs just 3.9 kg (8.7 lbs.) and was purpose built to serve as a multi-mission device. Its enhanced sensitivity and selectivity enables responders to displace other pieces of equipment in their toolkit, thus lightening the load associated with response missions. Similar to M908, MX908 is easy-to-use, shelf-ready and provides rapid chemical detection and identification of solids, liquids and vapors within seconds.

DECPOL represents the next generation in emergency CBRN dry decontamination solutions, composed of a super absorbent material permeated with advanced catalyzers. The DECPOL mitt absorbs a wide spectrum of contaminants such as nerve agents and biological agents, these are subsequently destroyed by the catalyzers contained within the mitt. The decontamination market has long struggled to overcome technology limitations associated with cross contamination and potential further contamination through powder dispersion, however the DECPOL mitt addresses these challenges with its innovative features.

BBI Detection continues to work closely with their international network of first responder and military end users to develop and supply a complimentary range of innovative products. BBI are committed to sourcing technology that will fill the capability gaps that exist across the CBRNe field, and the DECPOL mitt sits well alongside the IMASS device and wider product portfolio.

David Fraser, Marketing and Product Manager explains: “We’re really excited to add the DECPOL Emergency Decontamination Mitt to our range of products. The mitt complements our existing range of CBRN Detection systems and will allow us to offer to our customers a simple, efficient and effective dry decontamination solution.”

BBI Detection are launching the DECPOL Emergency Decontamination Mitt at IAFC Hazmat in Baltimore, USA on June 15 -17th 2017.

Since 2011, LION’s CBRN products have qualified as “Designated Status.” However, “Certified Status” acknowledges that LION’s CBRN products are recognized by the DHS Science and Technology branch as having significant, and effective technology that has the potential to save lives in the event of a terrorist incident.

As part of the application process for upgraded status, LION had to demonstrate to the DHS auditors that their PPE has performed as expected during the PPE’s ten-year life cycle. Information gathered via customer surveys included how often the suits were worn, whether they were cleaned and put back into service, or if they had been retired. LION showcased accurate record keeping of the entire life cycle of the PPE from fabric, suit, end-user receipt, and use.

“LION has achieved Safety Act ‘Certified Status’ by listening to the voice of the customer, and designing suits that first responders want to wear,” stated Diane Redden, Director of CBRN PPE and StationWear.
LION will hold certification until May 31, 2021.

FLIR Systems today announced the Griffin G510 Gas Chromatograph-Mass Spectrometer (GC/MS), its first person-portable chemical identifier.

The FLIR Griffin G510 comes equipped with an integrated heated sample probe designed for downrange missions. When used in survey mode, it identifies vapour-phase chemicals within seconds. The split/split-less injector allows for environmental, forensic, and hazardous material sampling by enabling syringe injection of organic liquids, a first for person-portable GC/MS systems.

Featuring a nine-inch touchscreen, the FLIR Griffin G510 can be operated while wearing full personal protective equipment when in a hot zone. When a chemical threat is automatically identified using industry-standard NIST library, the FLIR Griffin G510 alerts the operator with audible, visual, and color-coded alarms. Designed to withstand harsh environments, the FLIR Griffin G510 is IP65-rated, dust-tight and spray-resistant. Long-lasting, onboard, rechargeable batteries ensure every mission receives support from beginning to end.

“The FLIR Griffin G510 is a groundbreaking chemical analysis tool that brings versatility and lab quality performance and identification to the field.” said Dennis Barket, Jr., Vice President and General Manager of FLIR Detection. “The ability to quickly identify unknown threats and confirm known hazards gives responders confidence to take immediate action, ensuring the public’s safety.”

FLIR will showcase the FLIR Griffin G510 at the International Hazardous Materials Response Teams Conference hosted by the International Association of Fire Chiefs (IAFC) June 16-17, 2017 in Baltimore, Maryland, booth #1153. The FLIR Griffin G510 will be available for order worldwide in the second half of 2017 through FLIR and established distribution networks. More information is available here

The U.S. Army Chemical Materials Activity Recovered Chemical Materiel Directorate (RCMD) has decades of experience in destroying recovered chemical warfare materiel. In this case, the munition was recovered during a U.S. Army Corps of Engineers (USACE) planned remediation at Savanna Army Depot Activity (SVDA), Illinois.
“We have a team that worked for months to ensure all the requirements for safety, environmental compliance, logistics and funding were in place to accomplish this mission,” said Laurence Gottschalk, director of RCMD.
Nora Hawk, the USACE Louisville District Project Manager for SVDA, said the project was “truly an excellent and successful example of multi-agency and multi-discipline team collaboration.
“The SVDA Base Environmental Coordinator, Cathy Collins, remained in close coordination with RCMD throughout the planning, storage and destruction efforts and USACE team members from both Louisville District and Huntsville Center provided necessary management support,” Hawk said.
USACE works closely with RCMD for remediation efforts at sites that may have buried chemical munitions. A great deal of historical research goes into planning for remediation, and researchers typically have a good idea of what could be recovered at a site. When items with unknown liquid fills are recovered, RCMD sends specialized assessment equipment and a team of experts from CARA, the Chemical, Biological, Radiological, Nuclear and Explosive (CBRNE) Analytical and Remediation Activity, part of the U.S. Army 20th CBRNE Command. Assessment identifies the contents of munitions without opening them, which enhances safe, efficient operations.
After the item was assessed in December and confirmed to contain mustard agent, destruction mission planning began. Policy requires recovered chemical munitions to be destroyed at the closest DoD facility capable of hosting a mission, which in this case was SVDA. RCMD provided a temporary storage facility to SVDA, where the overpacked munition was secured until destruction.
In April, a team led by RCMD project manager Derek Romitti, with personnel from the Edgewood Chemical Biological Center, arrived in Illinois to set up the site for the Explosive Destruction System, the organization’s time-tested destruction technology to safely destroy the munition.
“Just to ensure the site was ready took months of coordination,” Romitti said. “We need to have power, water, security and personnel. Setting up the equipment and actually completing the EDS mission is the culmination of months of effort.”
The EDS is RCMD’s primary method for destroying recovered chemical munitions. First deployed in January 2001, the EDS has destroyed more than 2,600 recovered chemical warfare items in 12 states with an impeccable safety record. The system’s main component, a sealed, stainless steel vessel, contains all blast, vapor and fragments from the process. The EDS uses linear shaped cutting charges to explosively access the munition’s chemical payload for neutralization. Operators confirm treatment by sampling residual liquid and air from the vessel prior to reopening the EDS.
The process takes place in an environmental enclosure that operates under negative pressure and filters all air through a carbon filtration system. An extensive series of equipment checks, safety evaluations and regulatory approvals are required before operations begin.
Personnel are currently decontaminating the equipment before shipping it back to Maryland. Hazardous waste generated by this operation was shipped to a permitted treatment, storage and disposal facility.

The Austrian CBRN Defence Command based in Korneuburg have enhanced their CBRN training capability as a result of an investment in PlumeSIM, Argon’s Live instrumented CBRN field and virtual Tabletop CBRN / HazMat training system.

Supported by a number of RDS200 radiological simulators and LCD3.3 Chemical Warfare simulators, this new capability will enable the Command to implement a wide variety of Tabletop and Live Field Chemical Warfare, HazMat and Radiological CBRN exercises without the need to use any form of chemical warfare agent of simulant, or radiological sources.

Colonel Michael Schuster of the Austrian CBRN Defence Command, where CBRN education and training is delivered, reported “Large scenarios, which caused an immense input of simulants or were impossible to display, are now planned and executed easily. The lesson learned process is well supported via the After Action Review function. That leads to a high extend of simulation effectiveness.”

“We are delighted to have been awarded this contract which further demonstrates the acceptance of Argon CBRN training solutions, especially PlumeSIM, as the system of choice for the world’s leading CBRN / HazMat training facilities. Argon simulation systems help overcome restrictions in the use of CWA simulants and live radiological sources enabling our customers to provide realistic, effective training without compromising their environmental credentials or impacting upon health and safety” commented Steven Pike, Managing Director of Argon, adding “Although regrettable, realistic, effective and engaging CBRN / Hazmat training is no longer an option but a necessity in today’s climate.”

The CBRNe World office, like most people, were stunned by the events of March 22nd 2017 where a terrorist mounted Westminster bridge mowing down civilians and two police officers before murdering PC Keith Palmer. It was more poignant for the team as our CBRNe World event was opposite the Houses of Parliament and various members of the team had been regularly walking across the bridge in the preceding months. As such we felt that we needed to try and raise some money for the victims and commissioned Nick Spender, our regular artist, to create a commemorative image for the event. In addition to this picture we included the February 2016 cover of CBRNe World - Putin’s tea party - and the commemorative print was auctioned on the first day and the Alice/Putin one on the second.

In a further twist the successful bidder of the Commemorative image from the Australian CBRN product and training provider J37 found that one of the first policemen to the scene was a member of the SO15 Forensic Team that was attending the event. In a fantastic show of altruism the purchaser decided to donate the picture to the team for them to use as a commemoration of OP. Classific.

The auction raised £400 which will be donated to the Metropolitan Police Federation to be disbursed among the victims of the attack.

CBRNe Convergence Europe took place over three days in Westminster, as Central Hall a majestic building opposite Westminster Abbey and Big Ben. The first day was a pre-conference workshop run by Public Health England, looking at the psychosocial impact on crowds of CBRN attacks. The second day was the first full day of the conference which saw 240 people, 34 exhibitors, four clinics, a demo from the Metropolitan Police and hundreds of questions. The second day followed the same format, but had a demo from the London Fire Brigade.

The trial of the CBRN clinics was deemed a great success. These saw 12 moderators and four rapporteurs grilled by the audience, as they struggled with the big questions that make up a CBRN incident.

A full write up will be in the June edition of the magazine.

There have been many efforts to address this common problem over the years, from wipes to sprays to homemade concoctions. But cost-effective solutions have eluded protective apparel manufacturers until now.

“The anti-fog innovation is a huge advance for hazmat responders and chemical workers, where seeing better means working safer,” said Laura Kappler-Roberts, president and CEO of Kappler, Inc. “The response has been tremendous, which is really gratifying considering how long the industry has been trying to solve this problem.”

The patent-pending visor technology is being combined with another key “see better, work safer” improvement: A large, expanded-view visor which significantly increases the suit wearer’s field of vision with 17% more visor surface area.

The AntiFog Expanded-View Visor is being incorporated as a standard feature on all Kappler gas-tight suits made with Zytron® and Frontline® fabrics, including NFPA-certified styles.

For more details contact Kappler at 1-800-600-4019 or

Unretouched images show standard
visor on left after only a few minutes
in suit. Right image shows Kappler’s
AntiFog Expanded View Visor after
30 minutes of wear.

“The Second Sight is composed of different modules, providing it with unrivalled flexibility of use and versatility as well as compactness, deployability and operability” comments Romain Verollet, Manager in charge of the Defence & Security product range. “Another key advantage of our equipment is its ability to detect unexpected chemical threats in an asymmetric warfare scenario, no matter which is the type of gas used or the location of its dispersal” he adds.
The Second Sight MS is a remote gas-detection system employing an infrared sensor in real-time and designed to detect threats such as chemical warfare agents or toxic industrial gases. Second Sight MS permits the stand-off detection, identification and full visualization in real time of a gas cloud at ranges up to 5 km. The equipment has been certified by third party agencies as conforming to the requisite standards for military use in terms of its capacity to detect chemical warfare agents, water-and dust-proofing (IP standard), electromagnetic compliance (CEM) and resistance to vibration and shock (Mil-Std 810). Hence it is possible to gain the advantage of early warning of a chemical threat and to gather all the data needed to manage the attack: type of gas, location of source, extent and spread of contamination.

Russia’s Federal Administration for the Safe Storage and Destruction of Chemical Weapons said on its website that it had destroyed nearly all of its CWA stockpile. “In total, 39,002.86 tonnes, 97.6% of the overall chemical weapon stockpiles, have been destroyed.” As reported, Russia has finalized disposal of chemical weapons at six out of seven chemical arms disposal facilities. The disposal works are currently ongoing at one facility in Udmurtia’s Kizner.

Russian presidential envoy to the Volga Federal District Mikhail Babich, who is the head of the state commission for the disposal of chemical weapons, told President Vladimir Putin earlier that the disposal of chemical weapons in Russia was to be completed in 2017. The director of the Federal Administration for the Safe Storage and Destruction of Chemical Weapons, Col. Gen. Valery Kapashin, told Interfax that the disposal works would be finalized no later than October 2017.

Southwest Research Institute (SwRI) helped develop and recently completed initial testing of a field-deployable treatment system that destroys chemical warfare agents (CWAs) using locally available resources. The modular unit, designed to fit into a large shipping container for easy transport, includes two pollution abatement configurations – one wet and one dry process – that can be deployed depending on the available resources of the location.

Because current chemical destruction methods produce hazardous byproducts during the neutralization process, the Defense Advanced Research Projects Agency (DARPA) issued a call for innovative systems that can neutralize chemicals or dangerous material without creating hazardous waste. The resulting modular mobile unit can be easily transported and deployed in a field setting close to where hazardous chemicals may be stored.

“It is in our national interest to have a field operable unit that can safely dispose of chemical warfare agents and other dangerous chemicals on the front lines in a timely manner,” said Darrel Johnston, a senior program manager in SwRI’s Chemistry and Chemical Engineering Division. “We began development of the soil scrubber system in June 2016 and delivered a proof-of-concept system in February 2017.”

SwRI designed the dry pollution control process, ideal for arid or remote regions, for use with SwRI’s Dedicated EGR engine thermal destruction device developed for DARPA’s Agnostic Compact Demilitarization of Chemical (ACDC) Agents program. Once the chemicals are destroyed, exhaust gases pass through the SwRI soil-based fluidized bed where the combusted byproducts are captured. The used soil remains non-hazardous. The wet pollution control system, developed by a Canadian company for its stand-alone plasma torch treatment device, includes a liquid scrubber system. Using local soil eliminates the significant logistical burden of providing water to remote sites and transporting liquid waste to a treatment facility.

The performance of both the wet and the dry scrubber units were independently verified and validated in recent tests performed in Canada.  When the dry soil-based scrubber was interfaced with the Canadian company’s plasma torch front end, the system demonstrated a more than 99.9999 percent destruction of simulated CWAs and effective scrubbing of acid gases.

The systems are scheduled to be tested this summer with authentic CWAs, in both the liquid-scrubber and soil-scrubber configurations.

FORT EUSTIS, Va. – Media are invited to cover Joint Task Force Civil Support (JTF-CS) members participating in joint training exercises Vibrant Response 17 (VR 17 at Camp Atterbury, Indiana, and Guardian Response 17 (GR 17) at Muscatatuk Urban Training Center, Indiana, April 24 to 30.

VR 17 is a mission validation command post exercise that tests the capabilities of the federal response to meet the expectations of the Nation. It provides realistic training to prepare chemical, biological, radiological and nuclear (CBRN) response units to integrate with civilian partners and respond to natural or manmade catastrophic CBRN events.

GR 17 is a capstone field training exercise, involving more than 5,000 active duty and reserve service members to validate the mission readiness of the Defense CBRN Response Force. The two exercises will run simultaneously using the same scenario.

For more information, or to travel with the unit to the Indiana exercise, contact Dr. Michael Brown at the JTF-CS Public Affairs Office at (757) 501-7851 or email or

Additional information about JTF-CS and the capabilities of the DCRF can be found online here: or

Throughout FLIR PRIMED’s video series, Grant Coffey, retired Portland Fire & Rescue Hazmat Team Coordinator and CBRNE expert for nearly 40 years, delivers industry insights and real-life experiences designed to keep responders prepared, by staying current with the industry standards and best practices.  In addition, each episode will conclude with a free field checklist, or downloadable guide, to increase subject knowledge for a safer and more successful response.

The first three episodes of FLIR PRIMED, along with free downloadable checklist and guidebooks, are available NOW            
• Episode 1: PRIMED – A tool you can use right now to stay prepared
o Grant introduces you to PRIMED – a tool responders can use right now to stay prepared.
• Episode 2: STOP – What are the cues and clues
o When responding to a scene, STOP! Grant discusses the cues and clues responders should pay attention to.
• Episode 3: RAD – Turn it on and put it on
o Radiation is not well understood. Grant covers the important safety basics responders need to know.

The next seven episodes of FLIR PRIMED will air between April 24 – June 26 on the FLIR PRIMED page.  An additional 20 videos will be release into the second half of 2017, featuring guest appearances by other industry leaders.

Questions or topics viewers would like to see featured on FLIR PRIMED can be submitted to

Battelle and Nanotherapeutics Form Alliance to Speed Up Process of Industry Bringing Medical Countermeasures to Market

Focus is on vaccines and therapeutics to counter Chemical, Biological, Radiological and Nuclear (CBRN) threats to U.S. Armed Forces

COLUMBUS, Ohio (April 5, 2017)—Battelle and Nanotherapeutics, Inc. announced today that the organizations have entered an alliance to bring together core research, development, test and evaluation (RDT&E) and manufacturing capabilities needed to expedite the development of medical countermeasures urgently required by the Department of Defense (DoD) to protect deployed military forces from CBRN threats. 

Chemical and biological weapons continue to threaten warfighter and civilian populations in war zones such as Syria. With the rising threats of terrorism, they also are a potential homeland security threat. In order to better protect the warfighter, the DoD urgently needs new countermeasures, including vaccines, post-exposure prophylactics and treatments for acute exposure reactions.

Battelle has provided RDT&E facilities and expertise to support DoD medical countermeasure programs for decades, while in 2013 the DoD awarded Nanotherapeutics a contract to build a state-of-the-art manufacturing facility in which to provide all the core services necessary to establish a Medical Countermeasure Advanced Development and Manufacturing (MCM ADM) capability.

“The alliance between the two companies will enable faster and more effective development of medical countermeasures to protect and treat military populations against chemical, biological, radiological and nuclear attacks and outbreaks of naturally occurring emerging and genetically engineered infectious diseases,” said Dr. Prasad Raje, President and CEO for Nanotherapeutics, Inc.

Historically, many commercial companies have shied away from participating in this space, primarily due to the challenges of developing these products along with the low anticipated return on investment (ROI). However, the recent expansion of the Food and Drug Administration Priority Review Voucher Program to include CBRN threat agents increases potential ROI, while the Nanotherapeutics/Battelle Strategic Alliance significantly reduces potential risks for companies desiring to develop medical countermeasures to CBRN threats.

“Battelle is in a unique position to provide a much-needed bridge between commercial companies interested in medical countermeasure development and the government agencies that need them,” said Julie Swick, Vice President and General Manager of Battelle’s Life Science Research business.

About Battelle

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries. For more information, visit  For more information about Battelle contact Katy Delaney at 614- 424-7208 or at .

About Nanotherapeutics, Inc.

Nanotherapeutics is a contract development and manufacturing organization (CDMO) that operates a U.S.-based 183,000 square foot, state of the art, single-use, multi-purpose, multi-product, BSL-3 capable facility offering clients extensive capabilities, including a pilot facility for performing optimization of upstream, downstream and formulation functions, bulk cGMP manufacturing, and analytical development for proteins, antibodies, viral vaccines and gene therapy drug products. The Company provides expertise from preclinical through FDA licensure in a variety of production platforms, including microbial and mammalian cell culture. The Company also owns a second, Czech Republic-based, 165,000 square foot, 6,000-liter capacity BSL-3 facility for manufacturing vaccines using its proprietary Vero cell platform. For more information, visit the company website at or contact Gary Ascani at 386-418-8745 or at

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a two-year contract with the Biomedical Advanced Research and Development Authority (BARDA), a division within the Office of the Assistant Secretary of Preparedness and Response, valued at $100 million for the delivery of BioThrax® (Anthrax Vaccine Adsorbed) to the Strategic National Stockpile (SNS). This contract satisfies BARDA’s notice of intent to sole source BioThrax that was issued on December 8, 2016 and is separate from and in addition to the company’s $911 million BioThrax procurement contract with the Centers for Disease Control and Prevention (CDC). BioThrax pricing under this BARDA procurement contract is the same as BioThrax pricing under the CDC follow-on contract.

“Emergent is pleased to support BARDA in its efforts to enhance the nation’s preparedness against the threat of anthrax,” said Adam Havey, executive vice president and president biodefense division at Emergent BioSolutions. “Emergent is committed to developing and manufacturing preparedness solutions that address our customers’ needs to protect against a broad spectrum of public health threats.”

Simultaneously with the execution of this procurement contract, the company signed a modification to its September 30, 2016 contract with BARDA for the development and procurement of NuThrax™ (anthrax vaccine adsorbed with CPG 7909 adjuvant), the company’s next generation anthrax vaccine candidate. The modification increases the number of doses of NuThrax to be delivered under the base period from two million to three million doses with a commensurate reduction in dose price for the initial deliveries. The modification also reduces the purchase price for doses to be procured during the option period by $100 million thereby reducing the total contract value to be up to $1.5 billion, from the previously disclosed $1.6 billion.

Contract HHSO100201700007C for the procurement of BioThrax and contract HHSO100201600030C for the advanced development and delivery of NuThrax have both been funded in whole or in part with Federal funds from the Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, at the U.S. Department of Health and Human Services.

About Emergent BioSolutions
Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally emerging public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at Follow us @emergentbiosolu.

Safe Harbor Statement
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including statements regarding the total potential realizable value of the contract, our strategy, future operations, prospects, plans and objectives with respect to BioThrax and any other statements containing the words “believes,” “expects,” “anticipates,” “intends,” “plans,” “estimates” and similar expressions, are forward-looking statements. These forward-looking statements are based on our current intentions, beliefs and expectations regarding future events. We cannot guarantee that any forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Investors are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, we do not undertake to update any forward-looking statement to reflect new information, events or circumstances.

There are a number of important factors that could cause the company’s actual results to differ materially from those indicated by such forward-looking statements, including appropriations for BioThrax procurement under the contract and our manufacturing capabilities and strategies. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from our expectations in any forward-looking statement. Investors should consider this cautionary statement, as well as the risk factors identified in our periodic reports filed with the SEC, when evaluating our forward-looking statements.

Are you interested in working on CBRNe World and some of our other great products? We are looking for a marketing communications professional, preferably with an interest in CBRN, for our team. More information can be found via the LinkedIn job site -

The deal announced Thursday March 16 will be the second largest acquisition in 3M’s history and will greatly expand its worker safety product offerings, especially in breathing and gas detection devices.

If the deal is completed in the second half of the year as expected, the North Carolina-based Scott Safety will add 1,500 employees and $570 million in annual revenue to 3M’s coffers.

The news was welcomed by industry analysts who noted that 3M has worked hard to expand its worker safety products. In its largest deal to date, 3M bought Capital Safety for $2.5 billion 19 months ago to gain a huge presence in the fall protection and worker-harness arena.

Now, it’s greatly expanding its firefighter breathing products by buying Scott Safety.

Scott is one of the world’s leading manufacturers of self-contained breathing apparatus systems, gas and flame detection instruments and other safety devices. Its products are largely used by firefighters, military and rescue teams who need reliable protection from environmental, dust and smoke hazards.

Battelle’s Live-Agent Test Week
APRIL 17-21, 2017

Battelle’s Live-Agent Test Week is an opportunity for manufacturers and developers of personal protective equipment to submit their materials for live chemical agent permeation testing.

Testing will be conducted in accordance with military standards or NFPA standards based upon individual needs.

Permeation test data will help accelerate research and development to enable developers to meet critical government test and evaluation requirements or be prepared for certification, ensuring materials can provide chemical agent protection against mission specific scenarios.

Visit the Battelle website for full details.

FLIR Systems, Inc. announced today that it has received a delivery order for 50 U.S. Army Chemical, Biological, Radiological, and Nuclear Dismounted Reconnaissance Sets, Kits, and Outfits (CBRN DR-SKO) systems. The delivery order is under a five-year indefinite delivery, indefinite quantity (IDIQ) contract from the U.S. Department of Defense, in support of the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) DR-SKO Program of Record. The order is valued at $54.2 million, with deliveries extending through the second quarter of 2018. 

The CBRN DR-SKO system is a set of mission specific kits that characterize and provide full spectrum CBRN dismounted reconnaissance capability utilized by the U.S. Military Joint Services, including units within the Army, Navy, Air Force, Marines, and National Guard Weapons of Mass Destruction-Civil Support Teams. The program has been in development since 2008 with FLIR Systems, Inc. as the prime contractor.

“We are honored to continue providing our turnkey DR-SKO solution that addresses the current and emerging threats by equipping U.S. soldiers with the best-in-class technology for their mission,” said Andy Teich, President and CEO of FLIR. “This delivery solidifies our continued support to provide innovative, mission-critical solutions to keep our country safe and maintain our stance as a leader in the CBRN market.”

Since the CBRN DR-SKO IDIQ was awarded in December 2014, over 100 systems have been delivered to the U.S. Department of Defense, with production being performed out of FLIR’s facility in Elkridge, Md.


About FLIR Systems
FLIR Systems, Inc. is a world leader in the design, manufacture, and marketing of sensor systems that enhance perception and awareness. FLIR’s advanced thermal imaging and threat detection systems are used for a wide variety of imaging, thermography, and security applications, including airborne and ground-based surveillance, condition monitoring, research and development, manufacturing process control, search and rescue, drug interdiction, navigation, transportation safety, border and maritime patrol, environmental monitoring, and chemical, biological, radiological, nuclear, and explosives (CBRNE) detection. For more information, go to FLIR’s web site at

Forward-Looking Statements
The statements in this release by Andy Teich and the other statements in this release about the contract and order described above are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates, and projections about FLIR’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including the following: the ability to manufacture and deliver the systems referenced in this release, changes in pricing of FLIR’s products, changing demand for FLIR’s products, product mix, the impact of competitive products and pricing, constraints on supplies of critical components, excess or shortage of production capacity, the ability of FLIR to manufacture and ship products in a timely manner, FLIR’s continuing compliance with U.S. export control laws and regulations, and other risks discussed from time to time in FLIR’s Securities and Exchange Commission filings and reports. In addition, such statements could be affected by general industry and market conditions and growth rates, and general domestic and international economic conditions. Such forward-looking statements speak only as of the date on which they are made and FLIR does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release, or for changes made to this document by wire services or Internet service providers.

Are you working on research which would be of interest to emergency first responders? If so, we’d like to invite you to submit an abstract for our CBRNe World Convergence 2017 which is taking place in Indianapolis (November 6-8).

Our Convergence events have had paper and poster session for the past six years, which have provided insight from agencies such as: the Israeli Defence Force, DHS, Kings College London, TNO, ECBC, EPA, North Carolina State U, Brookhaven Labs, the Czech Institute of Microbiology and others.

This is the 10th year of CBRNe Convergence - the most important annual congress for the global CBRNE community.

The papers and posters featured at our events are read by policy makers and responders from over 40 countries. All those chosen to speak will receive free entry and accommodation for the duration of the conference and workshops. If you wish to submit a poster-only presentation, you will receive a 20% discount off government delegate rates.

Your abstract should be 250-500 words and needs to include:
• Background (purpose/objective/rationale of the research, relationship to other areas if any)
• Methods
• Preliminary results
• Preliminary conclusion
• Potential impact to mission/warfighter (if known)

All submissions will be assessed and if you are chosen as a speaker, you will be granted a 20 minute speaking slot and your paper will be accepted for publication within CBRNe World Magazine. If you only want to be considered for a poster submission, please mark this on your abstract.

Send all abstracts to: or

Registration for the event is also now open:


Emergent BioSolutions announced that it has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $30.5 million to develop monoclonal antibody therapeutics for viral hemorrhagic fever. This task order will utilize the company’s Center for Innovation in Advanced Development and Manufacturing (CIADM) facility located in Baltimore, Maryland.

Using monoclonal antibodies from Mapp Biopharmaceutical Inc., the company will conduct technology transfer of process materials and information, perform process and analytical method development, execute small-scale production runs, and perform cGMP cell banking leading to cGMP manufacture of bulk drug substance. The task order consists of a 36-month period of performance with a base task order valued at $7.4 million and options that, if executed, will bring the total task order value over three years to up to $30.5 million.

“Protecting and enhancing life is at the core of Emergent’s mission, and one of the ways by which we are able to fulfill this mission is in partnership with BARDA as it addresses emerging public health threats,” said Adam Havey, executive vice president and president, biodefense division of Emergent BioSolutions. “Emergent’s CIADM is a great example of a public-private partnership that works towards a shared goal. We look forward to successfully executing this task order in collaboration with all parties involved.” 

This is the fourth BARDA Task Order awarded to Emergent under the CIADM program. Since its inception in 2012, Emergent’s CIADM facility has been utilized to respond to public health emergencies including Ebola and Zika.

This Task Order Number HHSO10033004T under contract HHSO100201200004I is funded by BARDA, within the Office of the Assistant Secretary for Preparedness and Response in HHS.

About Emergent BioSolutions
Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally emerging public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at Follow us @emergentbiosolu.

Safe Harbor Statement
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including statements regarding the exercise of options under the task order, are forward-looking statements. These forward-looking statements are based on our current intentions, beliefs and expectations regarding future events. We cannot guarantee that any forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Investors are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, we do not undertake to update any forward-looking statement to reflect new information, events or circumstances. There are a number of important factors that could cause the company’s actual results to differ materially from those indicated by such forward-looking statements, including the availability of funding and BARDA’s exercise of options under the task order; the success of the planned development programs; the timing of and ability to obtain and maintain regulatory approvals for the product candidates; and commercialization, marketing and manufacturing capabilities. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from our expectations in any forward-looking statement. Investors should consider this cautionary statement, as well as the risk factors identified in our periodic reports filed with the SEC, when evaluating our forward-looking statements.

The cost of cleaning up the UK’s existing nuclear facilities has been estimated to be between £95 billion and £219 billion over the next 120 years or so. The harsh conditions within these facilities means that human access is highly restricted and much of the work will need to be completed by robots.

Present robotics technology is simply not capable of completing many of the tasks that will be required. Whilst robotic systems have proven to be of great benefit at Fukushima Daiichi NPP, their limitations, which include relatively straightforward tasks such as turning valves, navigating staircases and moving over rough terrain, have also been highlighted.

The new group comprising Manchester, the University of Birmingham, University of the West of England (UWE) and industrial partners Sellafield Ltd, EdF Energy, UKAEA and NuGen has been funded with £4.6m from The Engineering and Physical Sciences Research Council.
It will develop robots which have improved, power, sensing, communications and processing power. They will also develop systems which are able to address issues around grasping and manipulation, computer vision and perception. Importantly the robots will be autonomous – able to operate without direct supervision by humans.

The University of Manchester’s Professor Barry Lennox, who is leading this project, said: “This programme of work will enable us to fundamentally improve RAS capabilities, allowing technologies to be reliably deployed in to harsh environments, keeping humans away from the dangers of radiation.”

Within the next five years, the researchers will produce prototype robots which will then be trialled in both active and inactive environments. It is anticipated that these trials will include using robotic manipulators to autonomously sort and segregate waste materials and to use multiple robots, working collaboratively, to characterise facilities that may not have been accessed for 40 years or more.
The technology will not only have potential for improving robots used at nuclear sites, but also in other hostile environments such as space, sub-sea, and mining. Or in situations such as bomb-disposal and healthcare which are dangerous or difficult for humans.

During the events, COBRA supported different missions based on agency and user requirements, keeping millions of residents and visitors safe. Previously, COBRA has supported Emergency Operations Centers, field deployed Command Posts, and HAZMAT response teams during similar large-scale events. 
COBRA is a turn-key, commercial-off-the-shelf emergency management solution designed to work on any modern web browser, including mobile-friendly formats for Microsoft, iOS, and Android mobile devices. Dynamis’ COBRA software provide a proven, scalable incident management / common operating picture solution that exceeds customer requirements during both National Security Events and daily activities.
Two Nations, One Software.
January was a busy month for Dynamis. Not only was it used to keep the nation’s capital safe during the inaugural events, the nation of Belgium went live on January 1 with a COBRA-based solution for their national Incident & Crisis Information Management System (ICMS). 
Capable of supporting up to 4000 users from the local to the federal level, Belgian emergency services will use the COBRA-based ICMS across the entire crisis cycle, including planning, exercises, incident management, and evaluation.
Belgium now uses COBRA as its single national repository for all emergency management related information. The system is used by 1,200 jurisdictions, 2,500 organizations, 4,000 active users, and maintains 60,000 emergency management related contacts. In addition, Belgium grants system access to each jurisdiction for managing their emergency management plans, exercise plans, After Action Reports (AARs), planning scenarios, national GIS layers, national vulnerable/critical facility layers, hospital bed status information, and more. 
This project requires COBRA to display critical and vulnerable facilities on a map, allow agencies to upload and manage personal GIS map layers, share information between local communities and Federal users, support four different languages (French, Dutch, German, and English), integrate with military/federal map servers using WMS feeds, and include custom crisis response forms.
“Thanks to ICMS using the COBRA software, the Belgian authorities can collaborate for their missions in the field of safety and security, and have a common situational awareness which is critical during emergencies.” - Peter Mertens, Belgium Department of Interior, Crisis Center Communications

BNC Scientific (San Rafael, CA) is rolling out a new line of nuclear area monitors with a rich feature set previously only available in consumer electronics. The new RadWall area monitors detect and alarm on nuclear radiation in real time. While there are several manufactures of radiation detection and isotope identification nuclear area monitors, the RadWall S300 is the first commercial system to offer IoT connectivity. This allows installation teams and system management to leverage universal protocols and widely available networking equipment. Existing IoT networks can be augmented to include many RadWall units, in addition to handheld isotope identifiers (RIIDs), PRDs or other detector solutions.

“To complement our handhelds, PRDs and backpacks, we are introducing some fixed monitoring solutions that provide accurate, real time data to a reachback location”, comments Allan Gonzalez, Detection Systems Product Manager. “Typical area monitor networks don’t need elaborate spectroscopy, so the lower cost and simplicity of a go-no go system makes sense”.

The consumer nature of the RadWall provides easy set up and management, but the detector system embedded is built for demanding industrial applications. The system uses a Silicon Photomulitiplier rather than PMT, which provides advantages in size, vibration sensitivity and response times. The detector material (YSO) is highly sensitive, meaning a very small change in radiation levels can be identified in real time and reported locally or to a network monitoring system.  The backup battery ensures that in a power outage, the system will continue to monitor for nuclear radiation while alarming the management about the power outage. An optional siren is also available to provide instant audible alarming for applications like laundry monitoring or waste processing where a user may need to mitigate the alarm immediately.  Applications like small medical offices can establish a network for as low as $2000.00. Larger applications like a waste processing facility can leverage existing network infrastructure and scalable detector modules, with full monitoring systems under $25,000.00.

For more information, or a video on setting up your own system, see

‘…nothing in his life became him like the leaving it…’
Macbeth, Act I, Scene IV

So farewell Kim Jong-nam. Previously you were at best a footnote, at worst a joke – the half-brother that wasn’t able to sneak into Disneyland and got sent home in shame. Now your life will be remembered in thousands of PowerPoint presentations, a Tussauds type of fame, in the same room as Alexander Litvinenko. Traditionally the way to deal with brothers (and sisters) that posed a court threat was to have them strangled with a silk rope. Instead it looks like Kim Jong-un had you strangled from within, your body cramping as your respiratory muscles gave up the ghost.

I have to admit that VX was a surprise to the editorial office. A variety of chats had resulted in the smug conclusion, based on the extremely limited facts available, that it was likely to be a fentanyl derivative. We were looking for something that would cause a rapid inhalational onset of death, burns to the face and for which it would be very difficult to get an antidote. I and other armchair toxicologists felt jowl wigglingly secure in this diagnosis.

Some individuals suggested a kind of organophosphate (OP), one even went so far as to suggest VX! These people were clearly well meaning, but wrong-headed. The signs and symptoms of OP are such that diagnosis would be quite swift, a couple of doses of atropine would see Jong-nam back on his feet in no time. VX would also leave tell-tale clues, traces that would quickly be detected with conventional chemical detectors. The delay in announcing the identity of the agent clearly indicated that either something esoteric (tetrodoxtoxin?) had been used or something that might normally be present in a body of a Macau frequenting playboy (like a heroin derivative).

The Victorian toxicology armchair now has been relegated to the back of the garage. VX. An agent that can only be manufactured via significant state facilities, the possession of which would not only definitively signal possession but also send a clear, negative signal to the world. The two girls that spread the agent on his face might well be ‘Lizard Tails’ (agents that can be cast off without loss), but at the same time represent a further source of forensic information and intelligence. What a mess.

Admittedly it was a plan so crazy it just might work. The Malaysian health authorities first thought that the death was a ‘heart stroke’ and nearly released the body to the DPRK authorities for cremation. This was largely due to Jong-nam travelling under a false name, so it seemed unlikely that the liquid rubbed over the face of a nobody had anything to do with the severe shortage of breath he faced. Only when South Korea stated that it was the prodigal son who had gone to sing with the bleedin’ choir invisible did counter terrorism and CBRN wheels start to turn.
How much the two girls involved in the attack knew is an area of intense speculation. From the grainy CCTV it doesn’t look as if the girl that spread the liquid on his face from behind was wearing gloves, but she took care to wash her hands in the bathroom after. Police reports stated that one of the girls in custody was also vomiting heavily, though this was long after Jong-nam died. It’s a fact that KLIA2, the terminal where the attack took place, screens people before boarding, meaning that individuals who were airside had not been checked for liquids, etc.
It also seems that the Malaysian police are worryingly ignorant about VX, with it being described as a radioactive chemical ( Equally concerning is the matter of what decontamination has, or has not, been done on the area. Minute amounts of VX can be fatal, and when you consider that at least one of the girls will have touched the soap dispenser, that Jong-nam will have wiped his face and inevitably have left some on a seat, a bag, a desk… All that leaves a further contact hazard, and at the very least will have been cleaned with a rag held by someone else. I wonder how many of the cleaning staff at KLIA2 have been off work with raging headaches, runny noses and sensitivity to light? They also continued to use the airport after the attack!

What does this all mean?
1. DPRK is now confirmed to have VX, rather than merely being suspected of it.
2. DPRK will use ambassadorial channels to bring toxic substances into third countries.
3. DPRK informers/disidents are at significant risk.
4. Malaysian health authorities need increased training in CBRN.
5. Malaysian police authorities need more chemical detection equipment.

In reality, like the Litvinenko case, it doesn’t add up to a lot. States have always used assassination in other countries as a final means of asserting their authority (Gerald Bull and Supergun anyone?). They even use esoteric chemical, biological and radiological means to do so (fentanyl in the foiled Mishal assassination) and this is not likely to change soon. The states involved traditionally hit the culprit’s regime with sanctions and life goes on as normal.

For DPRK sanctions won’t even register, their pariah status provides few levers of power against them. For Malaysia and other countries, this has showcased the necessity of having a CBRN defence capability. If Jong-nam had been killed with an esoteric poison, then the 11 days needed to get full toxicology results is acceptable, for a known CWA you would hope that all clinical doubt would have been removed in about 24 hours. As is often the case, the inquiry will inevitably find that shortcomings need to be filled, that CBRN training needs to be improved… all too late to prevent Kim Jong-nam pushing up daisies. 

L3 Sonoma EO announced today that it has been named as a prime contractor on the CSD by JPEO CBD.  The award is for the Technology Maturation and Risk Reduction (TMRR) phase of the overall CSD program. L3 Sonoma EO, along with partner companies Spectral Sensor Solutions, LLC (S3) and L2 Defense, Inc., will perform on this two-year program consisting of laboratory and final prototypes.

Utilizing S3’s extensive knowledge and experience with Laser Interrogation of Surface Agents (LISA) technology in a fielded, supportable line replaceable unit format, L3 Sonoma EO will mature the previously developed Joint Contaminated Surface Detector (JCSD)-based system for the CSD. LISA technology successfully demonstrates high-speed, on-the-move detection and identification of chemicals on surfaces.

“The L3 Sonoma EO team is extremely pleased to support this important program, which will reduce risk to soldiers on the battlefield,” said Doug Manfredi, General Manager of L3 Sonoma EO. “The CSD will provide a near real-time, on-the-move capability to detect and identify chemical warfare agents (CWAs), non-traditional agents (NTAs) and toxic industrial chemicals (TICs).”

The system’s detection/identification function will be designed to continually interrogate the surface, provide data for processing and apply algorithms to the data to detect and identify, in real time, any contaminant that may be present. When fielded, the CSD will be a leap forward in on-the-move chemical detection capability for the U.S. Army.

L3 Sonoma EO delivers high-performance sensor systems in support of the warfighter, leveraging configurable sensor payloads with optical and stabilization architectures designed by recognized subject matter experts. With a commitment to lean business processes, L3 Sonoma EO ensures technical performance, on-time delivery and overall cost-effectiveness for its products. To learn more about L3 Sonoma EO, please visit the company’s website

The CBRN sampling equipment and a certified transport packaging container will be delivered to INTERPOL’s BioTerrorism Prevention Unit.

Defence and security company Saab has received an order for delivery of specially customised CBRN (chemical, biological, radiological and nuclear) sampling equipment and a certified transport packaging container to INTERPOL’s BioTerrorism Prevention Unit.

Under the agreement with INTERPOL’s BioTerrorism Prevention Unit, Saab will supply a total of six sampling units, to be used in the field to combat bio-terrorism. The delivery also includes a certified packaging container designed for safe transportation of CBRN samples and other hazardous materials from the field to the laboratory. Delivery will take place in March 2017.

“With this order, Saab further strengthens its position as a supplier of advanced CBRN solutions, while contributing to increased preparedness and keeping people and societies safe. Saab’s CBRN equipment provides first responders with all the tools they need to conduct efficient, proper and secure field collection, and safe transportation, of all types of toxic materials,” says Jonas Hjelm, head of Saab business area Support and Services.

Bio-terrorism refers to the malicious use of bacteria, viruses or biological toxins to threaten or cause harm to humans, animals or agriculture, and there is a number of terrorist groups demonstrating an interest in and intent to use biological materials as weapons.

Saab offers a complete CBRN solution for protecting people and securing operational capabilities. Early warnings to units and personnel are a key factor in limiting CBRN threats. With Saab’s integrated solutions, CBRN specialists and decision-makers will have effective tools for detecting and identifying a wide range of threats and will receive all the support needed for fast and accurate early warning. Saab will assist the customer’s organisation in evaluating and integrating CBRN capabilities. Saab’s CBRN solutions include systems for automatic warning and reporting (AWR), sampling equipment, certified transport packaging and a wide range of services and CBRN training and support solutions for individual protection.

INTERPOL is the world’s largest international police organisation, with 190 member countries. INTERPOL’s BioTerrorism Prevention Unit works with law enforcement, health, academia and industry to tackle bio-terrorism. Over the last few years, INTERPOL has increased its capacity to assist member countries in minimising and counteracting threats of a bio-terrorism and establish effective countermeasures as part of a global security strategy. INTERPOL’s BioTerrorism Prevention Unit will primarily utilise Saab’s CBRN products to train its various member countries.

Chemical, Biological, Radiological and Nuclear (CBRN) security includes the protective and preventive measures to combat situations which involve these hazardous agents. CBRN security is a growing market worldwide owing to the concerns for protection of civilian lives and maintenance of economic stability. Threats from terrorist organizations and geo-political issues are the primary drivers of the global CBRN security market. The leading countries in the CBRN security market include the U.S., Russia, the U.K. and China among others.

The countries such as India, Japan, South Korea, France, Germany, Saudi Arabia, Israel and South Africa are expected to generate further demand for CBRN security in the recent future. With increasing initiatives of demilitarization such as reduction of CBRN weapons stockpile and growing investments in the CBRN resistance technologies, the CBRN security products are expected to be developed by the manufacturers with better effectiveness, detection capabilities, and rapid decontamination functions. Moreover, the industry encounters several major restraints such as the soaring expenditure in research, design and development of CBRN security equipment, which has high impact presently and restricts the growth of the market. However, the impacts of these factors are expected to reduce over the period of forecast.

In this report, the market has been segmented based on type, function and geography. It also includes drivers, restraints and opportunities (DROs). The study highlights current market trends and provides the forecast from 2014 to 2021. The report covers the current market scenario for CBRN security and highlights future trends that could affect the demand for the same. The global CBRN security market is anticipated to observe a sturdy growth from 2015-2021 at a substantial CAGR.

By geography, the market has been segmented into North America, Europe, Asia Pacific and Rest of the World (RoW). Based on the type, the market has been categorized into chemical, biological, radiological and nuclear security. Additionally, the market has been segmented on the basis of functions which include protection equipment, detection equipment, decontamination equipment and simulation equipment. The market size and forecast from 2015 to 2021 have been provided in the report.

Analysis of macro and micro economic factors driving and restraining the growth of the global CBRN security market has been covered under the scope of the study. The market attractiveness analysis provided in the report, highlights the major areas for future investments in this CBRN security industry. The report is intended to help security contractors, original equipment manufacturers (OEMs) and suppliers in understanding the current and upcoming opportunities in the global CBRN security market and formulating their business strategies accordingly. In addition, governments, military organizations and other buyer communities can also benefit from the report.

This study includes the profiles of key players in the global CBRN security market and the strategies adopted by them to sustain in the competition. Recent developments by the key players in the market are expected to help the emerging players to design their strategies in an effective manner. The study is expected to help key players in the market and governments across the world to formulate and develop new strategies related to CRBN security equipment. The key participants in this market are Argon Electronics (U.K.) Ltd., Bruker Corporation, FLIR Systems, Inc., Blücher GmbH, HDT Global, AirBoss Defense, Inc., General Dynamics Corporation, MSA Safety, Inc., Kärcher Futuretech GmbH and Thales Group among others.

About TMR

TMR is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Leidos, a global science and technology company, was awarded a contract by the Defense Threat Reduction Agency (DTRA) to support DTRA’s Cooperative Biological Engagement Program (CBEP) and Cooperative Threat Reduction (CTR) Program through a worldwide Scientific & Technical Engagement Partnership (STEP) program. The single-award, time and materials contract has a one-year base period of performance, four one-year options, and a total contract value of approximately $170 million if all options are exercised. Work will be performed primarily in Northern Virginia and internationally in several combatant command areas of responsibility.

DTRA provides the Department of Defense’s core intellectual, technical, and operational support expertise for countering threats posed by weapons of mass destruction and high-yield explosives. The CTR Program promotes collaboration with international and non-governmental partners to advance regional engagement and multilateral cooperation in the biological warfare non-proliferation sector. The STEP Program will build long-term partnerships between strong research and technical centers and CBEP partner-country institutions to reduce biological threats through enhanced biological safety and security, awareness of biological risks, and knowledge related to biological pathogen research in foreign countries.

Under this new contract, Leidos will partner with industry, research institutions, non-governmental organisations, and local scientists to develop collaborative overseas research programs, and provide specialized training in laboratory research and containment facilities engineering, public health preparedness and emergency response, and disease outbreak field surveillance and response.

“Leidos is proud of the decades of support we have provided to DTRA’s critical mission and we are honored to have been selected to support DTRA’s key international partner engagement,” said Leidos Defense and Intelligence President, Tim Reardon. “The international assistance provided under this contract will strengthen US Government international outreach in countering threats posed by weapons of mass destruction, particularly biological weapons. This outreach, research, and training will help the US and our international partners prevent or mitigate CBRNE events throughout the world.”

About Leidos
Leidos is a global science and technology solutions leader working to solve the world’s toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company’s 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported pro forma annual revenues of approximately $10 billion for the fiscal year ended Jan. 1, 2016 after giving effect to the recently completed combination of Leidos with Lockheed Martin’s Information Systems & Global Solutions business (IS&GS).

For more information, visit 

Arktis Radiation Detectors is set to accelerate growth plans and the market reach of its innovative radiation detection product line following major additional funding from new and existing investors.

Venture Capital firms b-to-v Partners AG and AM-Tec Kredit AG, managed by aventic partners AG, have joined existing investors in committing $10 million in new funding.

Arktis’ mission is to provide smart tools to avoid trafficking of illicit radiological and nuclear materials around the globe. The new investment will enable the company to step up production of its next generation radiation detection systems, which feature proprietary technology developed by the scientists and engineers at its headquarters in Zurich.

Arktis products leverage the use of natural helium as opposed to the scarce and expensive He-3 isotope or other, sometimes even toxic materials used in many legacy systems.

Demand for its systems is growing rapidly and the company has recently secured contracts with the Defense Advanced Research Projects Agency (DARPA) in the US, supporting its revolutionary SIGMA program, as well as with the UK-based Atomic Weapons Establishment (AWE). In addition, it has won a contract at the port of Antwerp for seven radiation portal monitors fully integrated into the port’s infrastructure and with the Swiss authorities for radiation detection.

Arktis works with governments and agencies across the globe, supplying systems that improve security at ports, airports and border crossings. Its products are also well received in the nuclear safeguards community, which includes working with the University of Florida, the Korean Institute for Nuclear Nonproliferation and Control (KINAC) and Korean universities to improve the safe storage of spent nuclear fuel.

Rico Chandra, Chief Executive Officer of Arktis Radiation Detectors, said the new funding will accelerate the company’s continued growth and enable it to exploit the opportunities that are now emerging for its technology, particularly in the US and Europe. It will also allow the company to explore new market opportunities, expand its sales force and ramp up production for volume manufacturing.

He commented: “This new investment comes at a very exciting time for our company and will provide a massive boost to our expansion plans. Our systems are already making a major contribution to security across the globe and we continue to see a growth in demand. We will now be able to focus on bringing our portfolio of products to a whole new range of customers.”

Dr. Peter Balsiger, prospective board member for Arktis Radiation Detectors representing shareholder AM-Tec Kredit AG, said: “AM-Tec Kredit AG supports the most promising high-tech companies in Switzerland with expertise, entrepreneurial support, equity, networking and strategic know-how. We identified Arktis as one of the most promising technology companies and were particularly impressed by its market segment, trend, vision, product maturity, founders and team, as well as the sales ramp-up. We are happy to support its fast growth plan and to be part of what we believe will be a great success story.”

Dr. Helmut Schmidt, board member and lead investor for b-to-v, added: “We identified Arktis as having a leading technology with the potential to assist in addressing significant public and private safety needs. We are excited to be taking part in the company’s expansion because we regard both the present product offering and the vision to provide comprehensive networked systems as essential in the light of mounting homeland security issues around the world.”

About AM-Tec Kredit AG

AM-Tec Kredit AG is an Equity and Venture Capital firm located and managed by aventic partners AG in Zurich. Investors of AM-Tec Kredit AG are “Stiftung zur Förderung von KMU” owned by Berner Kantonalbank and Swissmem that unites the Swiss electrical and mechanical engineering industries and associated technology-oriented sectors. aventic partners AG is a Swiss private markets investment manager. Since 1999, it has specialized in the Swiss marketplace and managed a large number of investments. Focussing on high-potential growth plans, it realises potential in private markets by financing and developing great companies, creating superior value in its investments through active and long-term responsible ownership.

About b-to-v Partners AG

b-to-v Partners AG is a venture capital firm based in St. Gallen and Berlin. With some 200 members, it is also one of the leading networks of entrepreneurial private investors in Europe. b-to-v combines the industry expertise and experience of its members with the venture capital expertise of its own team. With this investment approach, b-to-v is committed to achieving sustained added-value for its portfolio companies as well as for its investing members. Investing together and the enjoyment inherent in the mutual financial, technical and personal support from entrepreneur to entrepreneur form the core of the b-to-v philosophy.

The full programme for CBRNe Convergence Europe is now online and available to download on our events page. Check it out for details of our world class speaking panel, the details of planned live demonstrations and who will be exhibiting at our trade show.

Book now for your place at CBRNe Convergence Europe, which takes place in Central London from 16-18 May. Don’t miss out!

  • Follow us on Twitter
  • Subscribe to CBRNe news